rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
19	Acute leukemia	C0085669	12	525	1.49732448662e-11	9.571788413098237e-06	STAT5A,IL5,IL3RA,IL2RB,STAT5B,IL2,NRAS,INPP5D,JAK3,CSF2,IL3,JAK1
20	Juvenile myelomonocytic leukemia	C0349639	7	116	1.91057170085e-11	1.0075566750629723e-05	NRAS,INPP5D,JAK3,CSF2,IL3,SOS1,IL2RG
21	Cutaneous T-cell lymphoma	C0079773	8	255	2.15247819568e-11	1.057934508816121e-05	STAT5A,IL5,STAT5B,IL2,JAK3,CSF2,JAK1,IL2RA
22	Leukemia, T-cell acute lymphoblastoid (2)	C0023492	10	348	2.49559262144e-11	1.1083123425692695e-05	STAT5A,IL5,IL2RB,STAT5B,IL2,NRAS,JAK3,IL3,IL2RA,IL2RG
23	Chorioamnionitis	C0008495	7	195	2.87818657796e-11	1.1586901763224182e-05	IL5,IL3RA,IL2,IL5RA,CSF2,IL3,IL2RA
24	Bronchiolitis, Viral	C0006274	10	211	3.11746184423e-11	1.2090680100755668e-05	STAT5A,IL5,IL2RB,IL2,IL5RA,CSF2,IL3,JAK1,IL2RA,IL2RG
25	Sarcoma, Ewing	C1261473	11	829	3.21290771765e-11	1.2594458438287154e-05	STAT5A,IL5,IL3RA,STAT5B,NRAS,CA9,CSF2RA,CSF2RB,CSF2,SOS1,IL2RG
26	Respiratory Syncytial Virus Infections	C0035235	10	299	3.33937322239e-11	1.309823677581864e-05	STAT5A,IL5,IL2RB,IL2,IL5RA,CSF2,IL3,JAK1,IL2RA,IL2RG
27	Chronic myeloid leukemia	C0023473	15	822	3.40311112623e-11	1.3602015113350127e-05	STAT5A,IL5,INPPL1,STAT5B,IL2,NRAS,IL5RA,INPP5D,JAK3,GRB2,CA9,CSF2,IL3,IL2RA,SOS1
28	T-cell lymphoma	C0079772	11	302	3.44243522576e-11	1.4105793450881612e-05	IL5,IL2RB,STAT5B,IL2,JAK3,CSF2,IL3,JAK1,IL2RA,SOS1,IL2RG
29	Leukemia, Large Granular Lymphocytic	C1522378	5	54	3.50919293624e-11	1.46095717884131e-05	STAT5A,IL2RB,STAT5B,IL2,IL2RA
31	T-Cell Prolymphocytic Leukemia	C0023494	6	30	3.69229091746e-11	1.5617128463476073e-05	STAT5A,STAT5B,IL2,JAK3,JAK1,IL2RA
32	Multiple Myeloma	C0026764	15	1236	3.70870001376e-11	1.6120906801007555e-05	STAT5A,IL5,INPPL1,IL2RB,STAT5B,IL2,NRAS,INPP5D,JAK3,GRB2,CSF2,IL3,JAK1,IL2RA,SOS1
33	Leukemogenesis	C0598766	12	660	3.80427911395e-11	1.662468513853904e-05	STAT5A,IL3RA,STAT5B,IL2,NRAS,JAK3,CSF2,IL3,JAK1,IL2RA,SOS1,IL2RG
34	Myeloproliferative Disorders	C0027022	9	245	3.84610121529e-11	1.712846347607053e-05	STAT5A,IL2RB,STAT5B,NRAS,INPP5D,JAK3,CSF2,IL3,JAK1
35	Leukemia, Lymphocytic, Chronic, B-Cell	C0023418	17	1913	4.17000878272e-11	1.7632241813602016e-05	STAT5A,IL5,IL3RA,IL2RB,STAT5B,IL2,NRAS,INPP5D,JAK3,GRB2,CSF2RB,CSF2,IL3,JAK1,IL2RA,SOS1,IL2RG
36	Adult T-Cell Lymphoma/Leukemia	C0023493	11	469	4.38118430424e-11	1.8136020151133502e-05	STAT5A,IL5,IL2RB,STAT5B,IL2,JAK3,CSF2,IL3,JAK1,IL2RA,IL2RG
37	Tropical Spastic Paraparesis	C0030481	5	58	4.79905004624e-11	1.8639798488664988e-05	IL2RB,IL2,CSF2,IL2RA,IL2RG
38	Immunodeficiency due to defect in CD3-gamma	C0021051	10	571	4.90519846963e-11	1.9143576826196474e-05	STAT5A,IL3RA,IL2RB,STAT5B,IL2,JAK3,CSF2,IL3,IL2RA,IL2RG
39	Acute myeloid leukemia	C0023467	15	1733	5.13615816544e-11	1.964735516372796e-05	STAT5A,IL5,IL3RA,IL2RB,STAT5B,IL2,NRAS,INPP5D,JAK3,CSF2RB,CSF2,IL3,JAK1,IL2RA,SOS1
40	Severe combined immunodeficiency due to ADA deficiency	C0085110	10	545	5.39047695369e-11	2.0151133501259446e-05	STAT5A,IL5,IL2RB,IL2,NRAS,JAK3,CSF2,IL3,IL2RA,IL2RG
42	Lymphoproliferative disorder	C0024314	7	236	5.4528048743e-11	2.115869017632242e-05	IL5,IL2RB,IL2,NRAS,JAK3,JAK1,IL2RA
43	Autoimmune disease 1	C0004364	11	890	5.48476819517e-11	2.1662468513853903e-05	STAT5A,IL2RB,STAT5B,IL2,NRAS,JAK3,CSF2,JAK1,IL2RA,SOS1,IL2RG
44	Chronic eosinophilic leukemia	C0346421	7	35	5.55805401703e-11	2.216624685138539e-05	STAT5A,IL5,STAT5B,IL2,IL5RA,CSF2,IL3
45	Eczema	C0013595	9	474	5.73219249844e-11	2.2670025188916875e-05	STAT5A,IL5,IL2RB,STAT5B,IL2,IL5RA,CSF2,JAK1,IL2RA
46	Eosinophilia	C0014457	7	175	6.56238396957e-11	2.3173803526448364e-05	IL5,IL2,IL5RA,CSF2,IL3,IL2RA,IL2RG
48	T-cell acute lymphoblastic leukemias	C1961099	8	371	7.64187602087e-11	2.4181360201511336e-05	IL2,NRAS,INPP5D,JAK3,CSF2,JAK1,IL2RA,IL2RG
49	Chronic Lymphocytic Leukemia	C0023434	13	1176	7.74729169706e-11	2.468513853904282e-05	STAT5A,IL5,STAT5B,IL2,NRAS,IL5RA,JAK3,CSF2RA,CSF2,IL3,JAK1,IL2RA,IL2RG
50	Hypereosinophilic syndrome	C1540912	5	26	7.89498466602e-11	2.5188916876574308e-05	IL5,IL2,IL5RA,CSF2,IL3
51	Premature Birth	C0151526	8	376	7.91274823442e-11	2.5692695214105794e-05	IL5,IL3RA,IL2RB,IL2,IL5RA,CSF2,IL3,IL2RA
52	Undifferentiated leukemia	C1378511	5	76	8.55804316302e-11	2.619647355163728e-05	STAT5A,STAT5B,NRAS,IL3,IL2RA
53	Fetal Membranes, Premature Rupture	C0015943	7	194	8.77675709887e-11	2.6700251889168766e-05	IL5,IL3RA,IL2,IL5RA,CSF2,IL3,IL2RA
54	Sezary Syndrome	C0036920	6	151	8.83362272219e-11	2.7204030226700255e-05	STAT5A,IL5,STAT5B,IL2,NRAS,IL2RG
55	Myeloid leukemia	C0023470	13	533	9.50174383618e-11	2.7707808564231737e-05	STAT5A,IL5,IL2RB,STAT5B,IL2,NRAS,INPP5D,JAK3,CSF2,IL3,JAK1,IL2RA,SOS1
56	Disorder characterized by eosinophilia	C1636667	6	141	9.75761693667e-11	2.8211586901763223e-05	IL5,IL2,IL5RA,CSF2,IL3,IL2RA
57	Premature Obstetric Labor	C0022876	7	203	1.03138608765e-10	2.871536523929471e-05	IL5,IL3RA,IL2,IL5RA,CSF2,IL3,IL2RA
58	Eosinophilic disorder	C1306759	6	143	1.06531783395e-10	2.92191435768262e-05	IL5,IL2,IL5RA,CSF2,IL3,IL2RA
59	Essential thrombocythemia	C0040028	6	150	1.07749364986e-10	2.9722921914357684e-05	STAT5A,STAT5B,NRAS,CSF2,IL3,JAK1
60	Acute lymphoid leukemia	C0023449	10	824	1.14124820705e-10	3.022670025188917e-05	STAT5A,IL3RA,STAT5B,IL2,NRAS,INPP5D,JAK3,CSF2,IL3,JAK1
61	Acute Undifferentiated Leukemia	C0280141	5	81	1.15576992421e-10	3.0730478589420656e-05	STAT5A,STAT5B,NRAS,IL3,IL2RA
62	Dermatitis, Atopic	C0011615	9	567	1.18995591158e-10	3.1234256926952145e-05	STAT5A,IL5,IL2RB,STAT5B,IL2,IL5RA,CSF2,JAK1,IL2RA
63	B Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1	C1292769	8	385	1.19503962281e-10	3.173803526448363e-05	STAT5A,STAT5B,IL2,NRAS,JAK3,IL3,IL2RA,IL2RG
64	Idiopathic hypereosinophilic syndrome	C0206141	4	28	1.2482725964e-10	3.224181360201511e-05	IL5,IL2,CSF2,IL3
65	Precursor Cell Lymphoblastic Leukemia-Lymphoma	C1961102	10	854	1.42213130161e-10	3.27455919395466e-05	STAT5A,IL3RA,STAT5B,IL2,NRAS,JAK3,CSF2,IL3,JAK1,IL2RA
66	Hematological neoplasm	C0376545	9	615	1.44201206531e-10	3.324937027707808e-05	STAT5A,STAT5B,IL2,NRAS,JAK3,CSF2,IL3,JAK1,IL2RG
67	Asthma	C0004096	12	1454	1.45446099609e-10	3.375314861460958e-05	STAT5A,IL5,IL2RB,IL2,IL5RA,JAK3,CSF2RB,CSF2,IL3,JAK1,IL2RA,IL2RG
68	Myeloproliferative disorder (2)	C1292778	6	165	1.46507694865e-10	3.425692695214106e-05	STAT5A,STAT5B,NRAS,INPP5D,CSF2,JAK1
69	Rheumatoid arthritis	C0003873	13	1856	1.5380441365e-10	3.476070528967254e-05	STAT5A,IL5,IL2RB,STAT5B,IL2,IL5RA,JAK3,CSF2,IL3,JAK1,IL2RA,SOS1,IL2RG
70	Symptomatic human immunodeficiency virus infection	C0019693	13	1900	1.78232095749e-10	3.526448362720403e-05	STAT5A,IL5,IL2RB,STAT5B,IL2,NRAS,GRB2,SHC1,CSF2,IL3,JAK1,IL2RA,IL2RG
71	X-linked severe combined immunodeficiency	C1279481	4	35	2.03373651253e-10	3.5768261964735515e-05	IL2,JAK3,JAK1,IL2RG
72	Allergic rhinitis	C2607914	6	174	2.35053865261e-10	3.6272040302267004e-05	IL5,IL2RB,IL2,CSF2,IL3,IL2RA
73	Primary Myelofibrosis	C0001815	6	179	2.84112511295e-10	3.677581863979849e-05	STAT5A,STAT5B,NRAS,JAK3,CSF2,JAK1
74	Alveolar proteinosis	C0034050	4	40	3.269648996e-10	3.7279596977329976e-05	IL5,CSF2RA,CSF2RB,CSF2
75	Graft-versus-host disease, susceptibility to	C0018133	7	317	3.26970117648e-10	3.7783375314861465e-05	IL5,IL2,INPP5D,JAK3,CSF2,IL2RA,IL2RG
76	Malignant neoplasm of lung	C0242379	14	2460	3.51691342715e-10	3.828715365239295e-05	IL5,IL2RB,STAT5B,IL2,NRAS,IL5RA,JAK3,CA9,SHC1,CSF2,IL3,JAK1,IL2RA,SOS1
77	Polycythemia vera	C0032463	6	192	4.11835787695e-10	3.879093198992444e-05	STAT5A,STAT5B,NRAS,CSF2,IL3,JAK1
78	Immune dysfunction with T-cell inactivation due to calcium entry defect 1	C0021053	6	197	5.04327468676e-10	3.929471032745592e-05	IL5,STAT5B,IL2,CSF2,IL3,IL2RA
79	Acute megakaryocytic leukemia	C0023462	5	106	5.76669045849e-10	3.979848866498741e-05	IL2,NRAS,JAK3,CSF2,IL3
80	Hepatocellular carcinoma	C2239176	15	3108	6.72560895865e-10	4.030226700251889e-05	STAT5A,IL5,INPPL1,IL2RB,STAT5B,IL2,NRAS,GRB2,CA9,SHC1,CSF2,IL3,JAK1,IL2RA,SOS1
81	Lymphoma, Large B-Cell, Diffuse	C0024299	11	1362	7.79857178834e-10	4.0806045340050374e-05	STAT5A,IL5,STAT5B,IL2,NRAS,JAK3,CSF2,JAK1,IL2RA,SOS1,IL2RG
87	Severe congenital neutropenia	C1853118	4	50	9.94645477093e-10	4.3828715365239296e-05	STAT5A,STAT5B,CSF2,IL3
88	Preeclampsia/eclampsia 1	C0032914	7	371	1.13182652139e-09	4.433249370277078e-05	IL5,IL3RA,IL2,IL5RA,CSF2,IL3,IL2RA
89	Verotoxigenic Escherichia coli gastrointestinal tract infection	C0009450	10	1111	1.4948632332e-09	4.483627204030227e-05	IL5,IL3RA,IL2RB,IL2,NRAS,IL5RA,CSF2,IL3,JAK1,IL2RA
90	Refractory anemia	C0002893	4	55	1.64807811842e-09	4.534005037783375e-05	IL5,NRAS,CSF2,IL3
91	Respiratory tract infection	C0035243	7	404	2.19748874652e-09	4.5843828715365246e-05	IL5,INPPL1,IL2,NRAS,JAK3,IL2RA,IL2RG
92	Pleural effusion	C0032227	5	137	2.66213162625e-09	4.634760705289673e-05	IL5,IL2,CA9,IL2RA,SOS1
93	Hormone receptor positive tumor	C1446409	4	61	2.74330191896e-09	4.685138539042821e-05	STAT5A,STAT5B,CSF2,IL2RA
94	Secondary hypertriglyceridemia	C0027627	15	3444	2.82762258053e-09	4.73551637279597e-05	STAT5A,IL5,INPPL1,IL2RB,STAT5B,IL2,NRAS,JAK3,GRB2,CA9,SHC1,CSF2,JAK1,SOS1,IL2RG
95	Melanoma	C0025202	13	2386	2.88196877474e-09	4.785894206549118e-05	IL5,IL2RB,STAT5B,IL2,NRAS,JAK3,SHC1,CSF2,IL3,JAK1,IL2RA,SOS1,IL2RG
96	Acute promyelocytic leukemia	C0023487	7	431	3.57936713602e-09	4.836272040302267e-05	STAT5A,STAT5B,NRAS,CSF2,IL3,JAK1,SOS1
97	Tuberculosis	C0041296	8	652	3.99808686158e-09	4.8866498740554155e-05	IL5,IL3RA,IL2RB,STAT5B,IL2,GRB2,CSF2,IL2RA
98	B-cell lymphoma	C0079731	8	652	3.99808686158e-09	4.937027707808564e-05	STAT5A,IL5,STAT5B,IL2,NRAS,INPP5D,CSF2,IL2RA
99	{Atopy, susceptibility to}, 147050 (3)	C0392707	4	71	5.84368564649e-09	4.9874055415617133e-05	IL5,IL2,CSF2,IL3
100	Neoplasm of the liver	C0023903	10	1290	6.99269231408e-09	5.0377833753148616e-05	STAT5A,IL5,STAT5B,IL2,NRAS,SHC1,CSF2,IL3,JAK1,SOS1
101	Pneumonia	C0032285	7	471	7.07547875844e-09	5.0881612090680105e-05	IL5,IL2RB,IL2,IL5RA,JAK3,CSF2,IL2RG
103	Crohn Disease	C0010346	9	979	7.73334962734e-09	5.188916876574307e-05	STAT5A,IL3RA,STAT5B,IL2,GRB2,SHC1,CSF2,IL3,IL2RA
104	Inflammatory Bowel Diseases	C0021390	9	985	8.19927115092e-09	5.239294710327456e-05	IL5,IL2RB,IL2,JAK3,CSF2,IL3,JAK1,IL2RA,SOS1
105	Leukopenia	C0023530	6	301	8.45950731687e-09	5.289672544080604e-05	STAT5B,IL2,CSF2,IL3,IL2RA,IL2RG
106	Hepatitis C	C0019196	8	721	9.54118017926e-09	5.340050377833753e-05	STAT5A,IL2RB,IL2,INPP5D,GRB2,CSF2,JAK1,SOS1
107	Tumor necrosis	C0333516	5	170	9.58247370342e-09	5.390428211586902e-05	IL2RB,IL2,CA9,CSF2,JAK1
108	Bronchial Hyperreactivity	C0085129	5	170	9.58247370342e-09	5.440806045340051e-05	IL5,IL2RB,IL5RA,CSF2,IL3
109	Malignant neoplasm of vulva	C0375071	3	28	1.20535277315e-08	5.491183879093199e-05	IL2,CA9,CSF2
110	{Diphtheria, susceptibility to} (1)	C0012546	4	83	1.28998488558e-08	5.5415617128463475e-05	IL2,CSF2,IL3,IL2RA
111	Malignant tumor of urinary bladder	C0005684	10	1371	1.30736954596e-08	5.5919395465994964e-05	IL5,IL2,NRAS,IL5RA,JAK3,GRB2,CA9,CSF2,IL3,SOS1
112	Chronic Periodontitis	C0266929	5	182	1.44753823372e-08	5.642317380352645e-05	IL5,IL2,INPP5D,CSF2,IL2RA
117	Hydrops, lactic acidosis, and sideroblastic anemia	C0013604	6	335	1.77096923792e-08	5.894206549118388e-05	INPPL1,IL2RB,NRAS,IL2RA,SOS1,IL2RG
118	Leishmaniasis, Visceral	C0023290	4	89	1.8285972625e-08	5.944584382871537e-05	IL2RB,IL2,CSF2,IL2RA
119	Bladder carcinoma	C0699885	9	1087	2.08625334785e-08	5.994962216624685e-05	IL5,IL2,NRAS,IL5RA,GRB2,CA9,CSF2,IL3,SOS1
120	Histiocytic medullary reticulosis	C0019623	3	32	2.10468198425e-08	6.045340050377834e-05	IL5,IL2RA,IL2RG
121	Acute Erythroblastic Leukemia	C0023440	5	195	2.17209790154e-08	6.095717884130982e-05	STAT5A,INPPL1,STAT5B,NRAS,CSF2
122	Abnormality of fluid regulation	C2364164	6	346	2.20649745142e-08	6.146095717884131e-05	INPPL1,IL2RB,NRAS,IL2RA,SOS1,IL2RG
123	Diabetes mellitus type 1	C0011854	9	1104	2.41504110043e-08	6.19647355163728e-05	STAT5A,INPPL1,IL2RB,STAT5B,IL2,NRAS,CSF2,IL3,IL2RA
124	Allergic asthma	C0155877	5	200	2.53138433548e-08	6.246851385390429e-05	IL5,IL2,CSF2,IL3,IL2RA
127	Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma	C0079744	7	568	3.01157481175e-08	6.397984886649875e-05	IL5,IL2,NRAS,INPP5D,JAK3,IL3,SOS1
128	Squamous cell carcinoma of the head and neck	C1168401	8	825	3.03686006342e-08	6.448362720403022e-05	STAT5A,STAT5B,IL2,CA9,CSF2,JAK1,IL2RA,SOS1
129	Mumps	C0026780	3	35	3.05416066881e-08	6.498740554156171e-05	IL2RB,CSF2,IL2RA
130	Allergic disposition	C3539909	5	210	3.37845257325e-08	6.54911838790932e-05	IL5,IL2,CSF2,IL3,IL2RA
131	Myelofibrosis	C0026987	4	102	3.64550255538e-08	6.599496221662469e-05	STAT5A,STAT5B,CSF2,JAK1
132	Dermatitis and eczema	C0477474	3	37	3.84562851563e-08	6.649874055415616e-05	IL5,IL5RA,CSF2
138	Schizophrenia	C0036341	11	1947	4.12705333241e-08	6.952141057934509e-05	IL3RA,IL2RB,IL2,GRB2,CSF2RA,CSF2RB,CSF2,IL3,IL2RA,SOS1,IL2RG
139	Tumor Progression	C0178874	11	1969	4.67480923971e-08	7.002518891687658e-05	STAT5A,IL5,STAT5B,IL2,NRAS,GRB2,CA9,CSF2,JAK1,IL2RA,SOS1
140	Hairy Cell Leukemia	C0023443	4	110	5.32454657032e-08	7.052896725440807e-05	IL2RB,IL2,IL3,IL2RA
141	Dermatitis, Allergic Contact	C0162820	4	111	5.57166270898e-08	7.103274559193955e-05	IL5,IL2,CSF2,IL2RA
142	Idiopathic thrombocytopenic purpura	C0398650	4	111	5.57166270898e-08	7.153652392947103e-05	IL2,NRAS,JAK1,IL2RA
143	Myelodysplastic syndrome	C3463824	6	399	5.8403539116e-08	7.204030226700252e-05	IL5,NRAS,JAK3,CSF2,IL3,JAK1
144	Sinusitis	C0037199	4	114	6.36837770296e-08	7.254408060453401e-05	IL5,CSF2,IL3,IL2RG
145	Hay fever	C0018621	4	114	6.36837770296e-08	7.304785894206548e-05	IL5,IL2,CSF2RB,CSF2
146	Chronic myelomonocytic leukemia	C0023480	4	115	6.65319007664e-08	7.355163727959697e-05	IL3RA,NRAS,GRB2,CSF2
147	Prostatic Neoplasms	C0033578	10	1606	6.67113196906e-08	7.405541561712846e-05	STAT5A,STAT5B,IL2,NRAS,SHC1,CSF2,IL3,JAK1,IL2RA,SOS1
148	Immediate hypersensitivity	C0020523	4	117	7.25361326559e-08	7.455919395465995e-05	IL5,IL5RA,CSF2,IL3
149	Glioblastoma	C0017636	10	1645	8.53011802304e-08	7.506297229219143e-05	STAT5A,INPPL1,STAT5B,IL2,NRAS,CA9,SHC1,CSF2,IL2RA,SOS1
150	Abnormality of lung morphology	C4021760	7	651	8.59504157846e-08	7.556675062972293e-05	INPPL1,NRAS,JAK3,CSF2RB,IL2RA,SOS1,IL2RG
151	Lymphopenia	C0024312	4	122	8.94856565514e-08	7.607052896725442e-05	IL2,JAK3,IL2RA,IL2RG
152	Abnormality of the lymphatic system	C4021976	6	426	9.11458039043e-08	7.65743073047859e-05	INPPL1,NRAS,JAK3,IL2RA,SOS1,IL2RG
153	CARCINOMA OF VULVA	C0677055	3	46	9.44148559334e-08	7.707808564231739e-05	IL2,CA9,CSF2
154	Ovarian Neoplasms	C0919267	8	942	9.45674248909e-08	7.758186397984887e-05	STAT5A,STAT5B,IL2,NRAS,GRB2,CA9,CSF2,SOS1
155	Carcinogenesis	C0596263	14	3723	9.46504138399e-08	7.808564231738035e-05	STAT5A,IL5,STAT5B,IL2,NRAS,INPP5D,JAK3,GRB2,CA9,SHC1,CSF2,IL3,IL2RA,SOS1
156	Lymphoid leukemia	C0023448	5	252	9.9423158928e-08	7.858942065491184e-05	IL3RA,NRAS,GRB2,IL3,IL2RA
157	Short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay	C0013336	8	949	1.00714727447e-07	7.909319899244333e-05	IL3RA,INPPL1,STAT5B,NRAS,CSF2RA,CSF2,IL3,SOS1
158	Metastatic Renal Cell Cancer	C0278678	3	47	1.03180406663e-07	7.959697732997482e-05	IL2,CA9,CSF2
159	Brain neoplasm	C0006118	7	667	1.03502023951e-07	8.01007556675063e-05	STAT5A,STAT5B,IL2,NRAS,CA9,CSF2,IL2RG
160	Fibrosarcoma	C0016057	5	254	1.04196468675e-07	8.060453400503778e-05	IL2RB,IL2,NRAS,CSF2,JAK1
161	Celiac Disease	C0007570	6	436	1.06718185511e-07	8.110831234256927e-05	IL5,IL2RB,IL2,IL5RA,IL3,IL2RA
162	Anterior uveitis	C0042165	3	48	1.12427735011e-07	8.161209068010075e-05	IL2RB,IL2,IL2RA
163	Giant cell arteritis	C0039483	4	129	1.18279719241e-07	8.211586901763224e-05	IL2,CSF2,IL3,IL2RA
164	Abnormality of the lymph nodes	C0149727	4	130	1.22949973203e-07	8.261964735516373e-05	NRAS,JAK3,IL2RA,IL2RG
165	Anaplastic large cell lymphoma, ALK negative	C0206180	5	263	1.27898276969e-07	8.312342569269522e-05	IL2,JAK3,CSF2,JAK1,IL2RA
166	Transitional cell carcinoma of the bladder	C0279680	4	132	1.32632240302e-07	8.36272040302267e-05	IL2,NRAS,CA9,CSF2
167	Musculoskeletal Diseases	C0026857	4	132	1.32632240302e-07	8.41309823677582e-05	IL5,IL2RB,IL2,IL2RA
168	Meningioma	C0025286	6	452	1.36303350606e-07	8.463476070528968e-05	NRAS,JAK3,GRB2,CA9,CSF2,JAK1
169	Pregnancy Complications, Hematologic	C0032964	4	133	1.37728347838e-07	8.513853904282116e-05	IL5,IL2RB,IL2,IL2RA
170	Colon cancer	C0007102	10	1727	1.4007510829e-07	8.564231738035265e-05	STAT5A,INPPL1,STAT5B,IL2,NRAS,JAK3,CA9,CSF2,SOS1,IL2RG
171	Hepatitis C, Chronic	C0524910	6	455	1.42495861888e-07	8.614609571788414e-05	IL5,IL2,INPP5D,CSF2,JAK1,IL2RA
172	Precancerous Conditions	C0032927	6	455	1.42495861888e-07	8.664987405541561e-05	STAT5A,IL2,NRAS,CA9,IL2RA,SOS1
173	Abnormal immunoglobulin level	C1855755	4	134	1.42982990337e-07	8.71536523929471e-05	NRAS,JAK3,IL2RA,IL2RG
174	Abnormality of B cells	C4021748	4	136	1.53961148053e-07	8.765743073047859e-05	NRAS,JAK3,IL2RA,IL2RG
175	Abnormality of B cell physiology	C1849242	4	136	1.53961148053e-07	8.816120906801008e-05	NRAS,JAK3,IL2RA,IL2RG
178	Breast-ovarian cancer, familial 1	C0006142	15	4543	1.62542980964e-07	8.967254408060454e-05	STAT5A,IL5,INPPL1,STAT5B,IL2,NRAS,JAK3,GRB2,CA9,SHC1,CSF2,IL3,JAK1,IL2RA,SOS1
179	Rhinitis, Allergic, Seasonal	C0035455	4	138	1.6559752114e-07	9.017632241813601e-05	IL5,CSF2,IL3,IL2RA
180	Urticaria Pigmentosa	C0042111	3	53	1.68630932551e-07	9.06801007556675e-05	STAT5A,STAT5B,IL2RA
181	Acute GVH disease	C0856825	4	140	1.7795807461e-07	9.118387909319899e-05	IL5,IL2,INPP5D,IL2RA
182	Hematological Disease	C0018939	4	143	1.9776113136e-07	9.168765743073049e-05	NRAS,JAK3,CSF2,IL3
186	Mastocytosis	C0024899	3	57	2.26965836125e-07	9.370277078085642e-05	STAT5A,STAT5B,IL2RA
187	Noninfiltrating Intraductal Carcinoma	C0007124	5	291	2.32102435826e-07	9.420654911838791e-05	STAT5A,NRAS,CA9,IL2RA,SOS1
188	Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease	C0221013	3	58	2.43533191391e-07	9.47103274559194e-05	STAT5A,STAT5B,IL2RA
189	Lymphocytic Choriomeningitis	C0024266	3	58	2.43533191391e-07	9.521410579345088e-05	CSF2,IL3,IL2RA
190	Fetal Diseases	C0015929	4	151	2.5925990621e-07	9.571788413098237e-05	IL5,IL2RB,IL2,IL2RA
193	Uveitis	C0042164	4	154	2.8596455548e-07	9.722921914357682e-05	IL2RB,IL2,CSF2,IL2RA
194	Carcinoma of colon	C0699790	10	1856	2.90856447038e-07	9.773299748110831e-05	STAT5A,INPPL1,STAT5B,IL2,NRAS,JAK3,CA9,CSF2,SOS1,IL2RG
195	Measles	C0025007	4	155	2.95274270257e-07	9.82367758186398e-05	IL2RB,IL2,CSF2,IL2RA
196	Abnormality of humoral immunity	C3150510	4	157	3.14670054347e-07	9.874055415617127e-05	NRAS,JAK3,IL2RA,IL2RG
197	Solid tumour	C0280100	7	772	3.15867452527e-07	9.924433249370278e-05	STAT5A,IL2,CA9,CSF2,IL2RA,SOS1,IL2RG
198	Monosomy	C0026499	4	158	3.24764270809e-07	9.974811083123427e-05	STAT5A,IL3RA,STAT5B,NRAS
199	Nonalcoholic Steatohepatitis	C3241937	4	158	3.24764270809e-07	0.00010025188916876576	IL2RB,CSF2,IL3,IL2RA
202	Animal Mammary Neoplasms	C0024667	11	2352	3.31603174031e-07	0.00010176322418136021	STAT5A,INPPL1,STAT5B,IL2,GRB2,CA9,SHC1,CSF2,JAK1,IL2RA,SOS1
203	Abnormal respiratory system morphology	C4022992	7	778	3.35015101438e-07	0.00010226700251889169	INPPL1,NRAS,JAK3,CSF2RB,IL2RA,SOS1,IL2RG
204	Vitreoretinopathy, neovascular inflammatory, 193235 (3)	C0242852	3	63	3.40842309821e-07	0.00010277078085642318	NRAS,CSF2,SOS1
205	Recurrent respiratory infections	C3806482	5	318	3.90469132583e-07	0.00010327455919395466	INPPL1,NRAS,JAK3,IL2RA,IL2RG
206	46,XY gonadal dysgenesis, partial, with minifascicular neuropathy	C0041408	4	164	3.90768341796e-07	0.00010377833753148614	IL3RA,CSF2RA,CSF2,IL3
213	Abnormality of the respiratory system	C4018871	8	1121	4.12883016665e-07	0.00010730478589420655	INPPL1,STAT5B,NRAS,JAK3,CSF2RB,IL2RA,SOS1,IL2RG
215	Lymphocytosis	C0024282	3	69	4.92763533089e-07	0.00010831234256926953	IL5,IL2,CSF2
216	Aplastic anemia	C0002874	4	172	4.94803503726e-07	0.00010881612090680102	IL2,NRAS,CSF2,IL2RA
217	Metastatic melanoma	C0278883	5	333	5.11266317282e-07	0.0001093198992443325	STAT5A,IL2,NRAS,CSF2,SOS1
218	Wiskott-Aldrich syndrome, 301000 (3)	C0043194	3	70	5.22362119892e-07	0.00010982367758186398	IL2,CSF2,IL2RG
219	Bronchiolitis	C0006271	3	70	5.22362119892e-07	0.00011032745591939547	IL5,IL2,IL2RA
220	Diabetes mellitus type 2	C0011860	10	1972	5.35836922499e-07	0.00011083123425692695	STAT5A,IL5,INPPL1,IL2,IL5RA,GRB2,SHC1,CSF2,IL2RA,SOS1
221	Non-Hodgkin lymphoma	C0024305	6	556	5.5087854911e-07	0.00011133501259445844	STAT5A,IL5,STAT5B,IL2,CSF2,IL2RA
222	Chronic Chagas' disease	C0041234	4	176	5.54399415265e-07	0.00011183879093198993	IL2RB,IL2,CSF2,IL2RA
223	Thymoma	C0040100	4	176	5.54399415265e-07	0.00011234256926952142	IL2,NRAS,CSF2,IL2RA
227	Seborheic dermatitis	C0011603	4	181	6.36803613063e-07	0.00011435768261964735	STAT5A,IL5,STAT5B,IL2RA
228	Abnormality of the spleen	C4025749	5	347	6.50223396348e-07	0.00011486146095717884	INPPL1,NRAS,IL2RA,SOS1,IL2RG
229	Secondary hyperparathyroidism	C0020503	4	182	6.54454453408e-07	0.00011536523929471034	IL2RB,IL2,IL3,IL2RA
230	Acute monocytic leukemia	C0023465	3	75	6.90282745852e-07	0.00011586901763224182	IL2,CSF2,IL2RG
231	Paroxysmal nocturnal hemoglobinuria	C0024790	3	75	6.90282745852e-07	0.0001163727959697733	IL2,NRAS,CSF2
234	Myeloid neoplasm with beta-type platelet-derived growth factor receptor gene rearrangement	C2939461	3	76	7.28100076119e-07	0.00011788413098236776	STAT5A,STAT5B,CSF2
235	Aortic Aneurysm, Abdominal	C0162871	4	190	8.09323498996e-07	0.00011838790931989925	STAT5A,STAT5B,CSF2,IL2RA
237	Neuroblastoma	C0700095	9	1612	8.25790784975e-07	0.00011939546599496221	STAT5A,IL2RB,STAT5B,IL2,NRAS,GRB2,CSF2,IL3,IL2RA
258	Abnormality of lymphocytes	C0427546	4	194	8.96955751117e-07	0.00012997481108312342	NRAS,JAK3,IL2RA,IL2RG
259	Diabetes Mellitus, Type 1	C0011849	10	2081	9.18462697785e-07	0.0001304785894206549	STAT5A,INPPL1,IL2RB,STAT5B,IL2,SHC1,CSF2,IL3,IL2RA,SOS1
260	IMMUNE SUPPRESSION	C0021079	3	81	9.41230752782e-07	0.0001309823677581864	JAK3,CSF2,IL2RA
261	Connective Tissue Diseases	C0009782	4	196	9.43431057387e-07	0.00013148614609571787	IL5,IL2RB,IL2,IL2RA
265	Graves Disease	C0018213	5	374	1.00589765495e-06	0.00013350125944584383	IL5,IL2,GRB2,IL3,IL2RA
266	Adult type dermatomyositis	C0221056	3	83	1.03835938536e-06	0.0001340050377833753	IL2,CSF2,IL2RA
267	Carcinoma, Lewis Lung	C0243038	3	83	1.03835938536e-06	0.00013450881612090678	IL2,CSF2,IL2RG
268	Chlamydia Infections	C0008149	3	83	1.03835938536e-06	0.0001350125944584383	IL5RA,SHC1,CSF2
269	Pulmonary Disease, Chronic Obstructive	C0024115	5	377	1.05367275949e-06	0.0001355163727959698	IL5,STAT5B,IL2,CSF2,IL2RA
270	CNS infection	C0007684	3	84	1.08955029565e-06	0.00013602015113350126	JAK3,CSF2,IL2RG
271	Kidney Failure, Chronic	C0022661	6	616	1.09351328148e-06	0.00013652392947103277	IL2,SHC1,CSF2,IL3,IL2RA,SOS1
274	Dental malocclusion	C0024636	3	85	1.14266909912e-06	0.00013803526448362722	IL2RB,IL2RA,SOS1
275	Wheezing	C0043144	3	86	1.19764869655e-06	0.0001385390428211587	IL5,IL2,IL2RA
276	Anemia	C0002871	6	627	1.23048018741e-06	0.00013904282115869017	IL2,NRAS,CSF2,IL3,IL2RA,IL2RG
277	Experimental Autoimmune Encephalomyelitis	C0014072	5	389	1.26394306832e-06	0.00013954659949622168	IL5,IL2RB,IL2,CSF2,IL2RA
278	Neoplasm, Residual	C0242596	4	208	1.26414596091e-06	0.00014005037783375315	IL3RA,IL2,CSF2,IL3
281	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4	C0034069	5	392	1.3215699638e-06	0.0001415617128463476	IL5,IL2,CSF2,IL2RA,SOS1
282	Leprosy	C0023343	4	211	1.35641932841e-06	0.0001420654911838791	IL5,IL2,IL5RA,IL2RA
283	Ovarian epithelial cancer	C0677886	10	2172	1.4068489429e-06	0.00014256926952141058	STAT5A,STAT5B,IL2,NRAS,CA9,CSF2,JAK1,IL2RA,SOS1,IL2RG
284	Hepatomegaly	C0019209	5	397	1.42229516042e-06	0.00014307304785894206	INPPL1,NRAS,IL2RA,SOS1,IL2RG
286	Decreased antibody level in blood	C4048270	3	91	1.50257973042e-06	0.00014408060453400504	JAK3,IL2RA,IL2RG
287	Inflammation	C0021368	6	647	1.51645836233e-06	0.00014458438287153651	IL5,IL2RB,IL2,IL5RA,CSF2,IL2RA
288	Tuberculosis, Pulmonary	C0041327	4	218	1.59239545228e-06	0.00014508816120906802	IL5,IL2,CSF2,IL2RA
289	Epstein-Barr Virus Infections	C0149678	4	219	1.62859857666e-06	0.0001455919395465995	IL5,IL2,CSF2,IL2RA
290	Chronic graft-versus-host disease	C0867389	3	93	1.63952480003e-06	0.00014609571788413097	IL5,IL2,IL2RA
291	Lymphedema, primary, with myelodysplasia	C0024236	3	93	1.63952480003e-06	0.00014659949622166247	INPPL1,NRAS,SOS1
292	Severe Aplastic Anemia	C1883018	2	25	1.64213339915e-06	0.00014710327455919395	CSF2,IL3
293	Elevated C-reactive protein level	C4023452	2	25	1.64213339915e-06	0.00014760705289672542	IL2RB,IL2RA
294	Hodgkin Disease	C0019829	5	409	1.6900730978e-06	0.00014811083123425693	STAT5A,IL5,STAT5B,IL2,SOS1
295	Hypsarrhythmia	C0037769	3	94	1.71122892878e-06	0.0001486146095717884	CSF2,SOS1,IL2RG
296	Lipomatosis, Multiple	C3489413	2	26	1.85517648621e-06	0.0001491183879093199	STAT5A,STAT5B
297	Autoimmune antibody positivity	C4022660	2	26	1.85517648621e-06	0.00014962216624685138	IL2RB,IL2RA
298	Abnormal erythrocyte sedimentation rate	C0438217	2	26	1.85517648621e-06	0.00015012594458438286	IL2RB,IL2RA
299	Waldenstrom macroglobulinemia	C0024419	3	96	1.86176365535e-06	0.00015062972292191436	STAT5A,STAT5B,IL2RA
300	Respiratory failure	C1145670	5	418	1.91687825501e-06	0.00015113350125944586	IL5,INPPL1,CSF2RB,CSF2,IL3
301	Nasopharyngeal carcinoma, susceptibility to, 3	C2931822	6	671	1.9316080313e-06	0.00015163727959697734	STAT5A,STAT5B,IL2,IL2RA,SOS1,IL2RG
302	Fowlpox	C0016629	2	28	2.33462831223e-06	0.00015214105793450884	IL2,CSF2
303	Nasal polyposis	C0027430	4	236	2.34966539381e-06	0.00015264483627204032	IL5,IL2,JAK3,CSF2
304	Polymyositis	C0085655	3	102	2.37279872184e-06	0.0001531486146095718	IL2,IL2RA,SOS1
321	Bacteremia, susceptibility to, 2	C0004610	3	104	2.56415468314e-06	0.00016171284634760704	IL5,IL2,CSF2
322	Cystic hygroma	C0206620	2	29	2.6023627141e-06	0.00016221662468513854	NRAS,SOS1
323	Tumor Immunity	C1519680	3	105	2.6640550731e-06	0.00016272040302267002	IL2,CSF2,IL2RA
324	NOONAN-LIKE/MULTIPLE GIANT CELL LESION SYNDROME (disorder)	C0221198	3	105	2.6640550731e-06	0.0001632241813602015	NRAS,CSF2,SOS1
325	Elevated erythrocyte sedimentation rate	C0151632	2	30	2.88972264317e-06	0.000163727959697733	IL2RB,IL2RA
326	Gastric Mucosa-Associated Lymphoid Tissue Lymphoma	C1333782	2	30	2.88972264317e-06	0.00016423173803526447	IL2,IL2RA
327	Aplasia/Hypoplasia of the abdominal wall musculature	C4023909	2	30	2.88972264317e-06	0.00016473551637279595	NRAS,SOS1
328	Papillary thyroid carcinoma	C0238463	5	451	2.97186556131e-06	0.00016523929471032745	IL2,NRAS,CA9,IL2RA,SOS1
329	Thrombocytopenia, platelet dysfunction, hemolysis, and imbalanced globin synthesis	C0040034	4	253	3.30153727379e-06	0.00016574307304785893	NRAS,CSF2,IL3,JAK1
330	Synovitis	C0039103	3	111	3.32519701707e-06	0.00016624685138539043	IL2,CSF2,IL3
331	Visceromegaly	C0042782	5	461	3.37165934006e-06	0.00016675062972292193	INPPL1,NRAS,IL2RA,SOS1,IL2RG
332	Triple Negative Breast Neoplasms	C3539878	5	461	3.37165934006e-06	0.0001672544080604534	IL2RB,IL2,CA9,JAK1,IL2RG
333	Neutropenia	C0027947	4	255	3.43090525023e-06	0.0001677581863979849	STAT5B,NRAS,CSF2,JAK1
334	Decrease in T cell count	C0392756	2	32	3.52598529363e-06	0.0001682619647355164	IL2RA,IL2RG
335	Opportunistic Infections	C0029118	2	32	3.52598529363e-06	0.00016876574307304786	IL2,CSF2
336	Sarcoidosis	C0036202	4	257	3.56429946391e-06	0.00016926952141057937	IL5,IL2,CSF2,IL2RA
337	Dermatomyositis	C0011633	3	115	3.82878875493e-06	0.00016977329974811084	IL2,CSF2,IL2RA
338	Lupus Erythematosus, Systemic	C0024141	8	1467	3.87332572238e-06	0.00017027707808564232	STAT5A,IL5,IL2RB,IL2,CSF2,JAK1,IL2RA,SOS1
339	Chronic atrophic gastritis	C0017154	3	116	3.96303095551e-06	0.00017078085642317382	IL2,CSF2,IL2RA
340	Primary biliary cirrhosis	C0008312	4	263	3.98887519359e-06	0.0001712846347607053	IL5,IL2,IL2RA,SOS1
341	Cutaneous malignant melanoma 3	C0151779	4	264	4.06336770553e-06	0.00017178841309823677	NRAS,JAK3,CSF2,IL2RA
342	Malignant mesothelioma	C0345967	4	266	4.21565471942e-06	0.00017229219143576828	IL2RB,IL2,CSF2,SOS1
343	Ankylosing spondylitis	C0038013	4	269	4.45237761304e-06	0.00017279596977329975	IL2,CSF2RB,IL2RA,IL2RG
344	Abnormal platelet function	C0855740	2	35	4.64412003665e-06	0.00017329974811083123	NRAS,SOS1
345	Myelosuppression	C0854467	2	35	4.64412003665e-06	0.00017380352644836273	CSF2,IL3
346	Ileitis	C0020877	2	35	4.64412003665e-06	0.0001743073047858942	IL5,CSF2
347	Hepatitis B, Chronic	C0524909	4	272	4.6994823043e-06	0.0001748110831234257	IL2,CSF2,JAK1,IL2RA
348	Breast carcinoma	C0678222	13	4281	4.77205016247e-06	0.00017531486146095718	STAT5A,INPPL1,STAT5B,IL2,NRAS,JAK3,GRB2,CA9,SHC1,CSF2,JAK1,IL2RA,SOS1
349	Malnutrition	C0162429	3	122	4.84323185101e-06	0.00017581863979848866	STAT5A,STAT5B,IL2
350	Hepatitis, Autoimmune	C0241910	3	123	5.002862279e-06	0.00017632241813602016	IL5,IL2,IL2RA
351	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	C1140680	9	1967	5.03765229221e-06	0.00017682619647355164	STAT5B,IL2,NRAS,CA9,CSF2,JAK1,IL2RA,SOS1,IL2RG
376	Anemia, severe	C0238644	2	36	5.06315463655e-06	0.0001894206549118388	IL2,IL3
377	Lymphadenopathy	C0497156	3	124	5.16640096215e-06	0.00018992443324937028	NRAS,IL2RA,IL2RG
378	Classical Hodgkin's Lymphoma	C1333064	3	126	5.50525155152e-06	0.00019042821158690175	STAT5A,STAT5B,IL2
379	Abnormal urine phosphate concentration	C4022828	2	37	5.50654513354e-06	0.00019093198992443326	INPPL1,NRAS
380	Non-small cell lung carcinoma	C0007131	9	1993	5.6676933603e-06	0.00019143576826196473	STAT5A,STAT5B,IL2,NRAS,CA9,CSF2,JAK1,IL2RA,SOS1
381	Abnormality of abdomen morphology	C4020869	5	505	5.68836329096e-06	0.00019193954659949624	INPPL1,NRAS,IL2RA,SOS1,IL2RG
382	Glioma	C0017638	9	1997	5.77049681461e-06	0.0001924433249370277	IL2RB,STAT5B,IL2,GRB2,CA9,CSF2,IL3,IL2RA,SOS1
383	Splenomegaly	C0038002	4	285	5.89732516243e-06	0.0001929471032745592	INPPL1,NRAS,IL2RA,IL2RG
384	Chromosome 5, trisomy 5q	C1802398	2	38	5.97483340714e-06	0.0001934508816120907	IL5,CSF2
385	Polyarticular arthritis	C0162323	2	38	5.97483340714e-06	0.00019395465994962217	IL2RB,IL2RA
386	Lymphoma, AIDS-Related	C0085090	2	38	5.97483340714e-06	0.00019445843828715364	IL5,CSF2
387	Combined immunodeficiency, X-linked	C0494261	2	38	5.97483340714e-06	0.00019496221662468514	JAK3,IL2RG
388	Common variable immunodeficiency 2	C0009447	3	130	6.2321011588e-06	0.00019546599496221662	IL5,IL2,IL2RA
389	Lung Neoplasms	C0024121	7	1155	6.44827716645e-06	0.0001959697732997481	STAT5A,STAT5B,IL2,NRAS,CA9,CSF2,JAK1
390	Partial Trisomy	C1297882	2	39	6.4687942285e-06	0.0001964735516372796	IL3RA,IL3
391	Intracranial glioma	C3665419	2	39	6.4687942285e-06	0.00019697732997481107	CSF2,SOS1
392	Chronic diarrhea	C0401151	2	39	6.4687942285e-06	0.00019748110831234255	IL2RA,IL2RG
393	Schwannoma	C0027809	3	132	6.6209208478e-06	0.00019798488664987405	STAT5A,IL2RB,STAT5B
394	Pregnancy Complications	C0032962	3	132	6.6209208478e-06	0.00019848866498740556	IL5,CSF2,IL3
395	Colorectal cancer 1	C0009402	10	2543	6.63748998431e-06	0.00019899244332493706	STAT5A,INPPL1,IL2RB,STAT5B,IL2,NRAS,GRB2,CA9,CSF2,SOS1
396	Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations	C0239998	5	521	6.79876554999e-06	0.00019949622166246853	INPPL1,NRAS,JAK3,IL2RA,IL2RG
397	Abnormality of the immune system	C4021753	7	1164	6.82729963641e-06	0.0002	INPPL1,IL2RB,NRAS,JAK3,IL2RA,SOS1,IL2RG
398	Hypophosphatemia	C0085682	2	40	6.98894092754e-06	0.0002005037783375315	INPPL1,NRAS
399	Superficial ulcer	C0333307	3	134	7.0274644256e-06	0.000201007556675063	IL2RB,IL2,IL2RA
400	Recurrent fungal infections	C1844384	2	41	7.53610004844e-06	0.00020151133501259446	IL2RA,IL2RG
401	Primary Sjï¿½gren's syndrome	C0205225	2	42	8.11080951268e-06	0.00020201511335012597	STAT5A,STAT5B
402	Active tuberculosis	C0151332	2	42	8.11080951268e-06	0.00020251889168765744	IL2,IL2RA
403	Acute anterior uveitis	C0701807	2	42	8.11080951268e-06	0.00020302267002518892	IL2,IL2RA
431	Mammary Tumorigenesis	C1512981	3	141	8.59679715659e-06	0.00021712846347607054	STAT5A,NRAS,GRB2
432	Hashimoto thyroiditis	C0677607	3	142	8.84041340021e-06	0.00021763224181360204	IL2,NRAS,IL2RA
433	Malignant neoplasm of pancreas	C0346647	8	1625	8.93308895145e-06	0.00021813602015113352	STAT5B,IL2,NRAS,CA9,CSF2,JAK1,IL2RA,SOS1
434	Abnormality of cell physiology	C4023595	4	313	9.28896629382e-06	0.000218639798488665	NRAS,JAK3,IL2RA,IL2RG
435	Subacute Sclerosing Panencephalitis	C0038522	2	44	9.34557427335e-06	0.0002191435768261965	IL2,CSF2
436	Pulmonary artery stenosis	C0238397	2	44	9.34557427335e-06	0.00021964735516372797	NRAS,SOS1
437	Coarse hair	C0277959	2	44	9.34557427335e-06	0.00022015113350125945	NRAS,SOS1
438	Non-arthropod borne lymphocytic choriomeningitis	C0153014	2	44	9.34557427335e-06	0.00022065491183879095	CSF2,IL2RA
439	Enlarged thorax	C4020962	2	45	1.00069279145e-05	0.00022115869017632242	NRAS,SOS1
440	Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper-ige	C0011606	2	45	1.00069279145e-05	0.0002216624685138539	IL5,IL2RG
441	Chondrodysplasia acromesomelic with genital anomalies	C0343284	2	45	1.00069279145e-05	0.0002221662468513854	STAT5A,STAT5B
442	Fibrous tissue neoplasm	C0206643	2	45	1.00069279145e-05	0.00022267002518891688	NRAS,SOS1
443	Mammary Carcinoma, Human	C1257930	2	45	1.00069279145e-05	0.00022317380352644835	STAT5A,STAT5B
444	Arthropathy	C0022408	3	147	1.01360062665e-05	0.00022367758186397986	IL2RB,IL2,IL2RA
445	Malaria, Falciparum	C0024535	3	147	1.01360062665e-05	0.00022418136020151133	IL5,IL2,IL3
446	Short digit	C4023124	4	320	1.0337457794e-05	0.00022468513853904284	INPPL1,NRAS,SOS1,IL2RG
447	Colorectal cancer	C1527249	10	2681	1.10783782936e-05	0.0002251889168765743	STAT5A,INPPL1,IL2RB,STAT5B,IL2,NRAS,GRB2,CA9,CSF2,SOS1
448	Melanocytic nevus of skin	C3665593	2	47	1.1420982425e-05	0.0002256926952141058	NRAS,SOS1
449	Nijmegen Breakage Syndrome	C0398791	2	47	1.1420982425e-05	0.0002261964735516373	IL5,IL2
450	Thickened nuchal skin fold	C1836940	2	47	1.1420982425e-05	0.00022670025188916877	NRAS,SOS1
451	Toxoplasmosis	C0040558	2	47	1.1420982425e-05	0.00022720403022670024	IL2,CSF2
452	Scleroderma	C0036421	5	573	1.16868944312e-05	0.00022770780856423174	IL2RB,IL2,CSF2,IL2RA,SOS1
453	Abnormality of immune system physiology	C4023616	6	884	1.18161872611e-05	0.00022821158690176322	INPPL1,IL2RB,NRAS,JAK3,IL2RA,IL2RG
454	Esophageal Squamous Cell Carcinoma	C0279626	6	888	1.21679395348e-05	0.0002287153652392947	IL5,IL2RB,GRB2,CA9,IL2RA,SOS1
455	Neck Neoplasms	C0027533	2	48	1.21748297615e-05	0.0002292191435768262	IL5,CA9
456	Head and Neck Neoplasms	C0018671	4	333	1.25287230877e-05	0.00022972292191435767	STAT5A,STAT5B,CA9,IL2RA
469	 Adenocarcinoma, ovarian, somatic, 167000 (3)	C0001418	8	1700	1.28741981998e-05	0.00023627204030226702	STAT5A,IL5,STAT5B,IL2,NRAS,CA9,CSF2,SOS1
470	IgA deficiency	C0162538	2	49	1.29608404564e-05	0.0002367758186397985	IL5,IL2RA
471	Splenic Marginal Zone B-Cell Lymphoma	C0349632	2	49	1.29608404564e-05	0.00023727959697732997	IL2,IL2RA
472	Abdominal symptom	C0740651	6	901	1.33719584282e-05	0.00023778337531486147	INPPL1,NRAS,JAK3,IL2RA,SOS1,IL2RG
473	Prostate carcinoma	C0600139	10	2734	1.33791131698e-05	0.00023828715365239295	STAT5A,IL5,STAT5B,IL2,CA9,SHC1,CSF2,JAK1,IL2RA,SOS1
474	Rubella	C0035920	2	50	1.37796543197e-05	0.00023879093198992443	IL2RB,IL2RA
475	Carcinoma breast stage IV	C0278488	4	342	1.42472681297e-05	0.00023929471032745593	STAT5B,IL2,CSF2,SOS1
476	Progressive cGVHD	C3539781	3	161	1.45097383395e-05	0.0002397984886649874	IL2,NRAS,CSF2
477	Progressive Neoplastic Disease	C0677932	3	161	1.45097383395e-05	0.00024030226700251888	IL2,NRAS,CSF2
478	Phyllodes tumor, benign	C0010701	2	51	1.46318846173e-05	0.00024080604534005038	NRAS,CA9
479	Aural atresia, congenital	C1842937	2	51	1.46318846173e-05	0.00024130982367758186	NRAS,CSF2
480	Pemphigus	C0030807	2	51	1.46318846173e-05	0.00024181360201511336	IL5,IL2
481	Morphological abnormality of the inner ear	C4023381	2	51	1.46318846173e-05	0.00024231738035264484	NRAS,SOS1
482	Disseminated Malignant Neoplasm	C0346957	3	162	1.48677330525e-05	0.0002428211586901763	IL2,JAK3,CSF2
483	Pectus excavatum	C0016842	3	162	1.48677330525e-05	0.00024332493702770782	INPPL1,NRAS,SOS1
484	Abnormality of phosphate homeostasis	C4022032	2	52	1.55181904828e-05	0.0002438287153652393	INPPL1,NRAS
485	Guillain-Barre syndrome, familial	C0018378	2	52	1.55181904828e-05	0.00024433249370277077	IL2,IL2RA
486	Polyradiculoneuropathy, Chronic Inflammatory Demyelinating	C0393819	2	52	1.55181904828e-05	0.00024483627204030224	CSF2,IL2RA
487	Peptic Esophagitis	C0014869	2	52	1.55181904828e-05	0.0002453400503778337	IL5,IL2
488	Wilms Tumor	C0027708	4	352	1.63673107396e-05	0.00024584382871536525	IL2,NRAS,CSF2,SOS1
489	Hematopoietic Neoplasms	C0376544	3	168	1.7154347379e-05	0.0002463476070528967	STAT5A,STAT5B,IL2
490	Secondary malignant neoplasm of lung	C0153676	5	614	1.7285290157e-05	0.00024685138539042825	IL2,NRAS,GRB2,CSF2,SOS1
491	Zoonotic form of cutaneous leishmaniasis	C0023283	2	54	1.73954162989e-05	0.00024735516372795973	IL2,IL2RA
492	Abnormality of the abdominal musculature	C4023608	2	54	1.73954162989e-05	0.0002478589420654912	NRAS,SOS1
493	Fibroma	C0016045	2	54	1.73954162989e-05	0.0002483627204030227	NRAS,SOS1
514	Renal neoplasm	C0022665	4	363	1.89758961792e-05	0.0002589420654911839	IL2,NRAS,CA9,CSF2
515	Endometriosis of uterus	C0341858	2	56	1.94165588451e-05	0.00025944584382871536	IL2RB,SOS1
516	Radioulnar synostosis	C0158761	2	56	1.94165588451e-05	0.00025994962216624684	NRAS,SOS1
517	Autoimmune lymphoproliferative syndrome, type 2	C1328840	2	56	1.94165588451e-05	0.00026045340050377837	NRAS,IL2RA
518	Exanthema	C0015230	4	366	1.97407213792e-05	0.0002609571788413098	IL5,NRAS,CSF2,IL2RG
519	Joint swelling	C0152031	2	57	2.04827312922e-05	0.0002614609571788413	IL2RB,IL2RA
520	Chronic neutrophilia	C3665444	2	57	2.04827312922e-05	0.0002619647355163728	IL5,CSF2
521	Female pseudohermaphroditism	C0238394	2	57	2.04827312922e-05	0.00026246851385390433	JAK3,JAK1
522	Lymphoma, Large-Cell, Follicular	C0079745	3	176	2.05933453329e-05	0.00026297229219143575	STAT5A,STAT5B,IL2
523	Fetal ultrasound soft marker	C4023366	2	58	2.15865991551e-05	0.0002634760705289673	NRAS,SOS1
524	Neoplasms, Experimental	C0027659	2	58	2.15865991551e-05	0.00026397984886649875	IL2,NRAS
525	Abnormality of the uvea	C4025842	4	373	2.16189598489e-05	0.00026448362720403023	IL2RB,NRAS,IL2RA,SOS1
526	Dengue Fever	C0011311	3	179	2.20051900445e-05	0.0002649874055415617	IL3RA,CSF2,IL2RA
527	Thyroid Diseases	C0040128	4	376	2.24653157438e-05	0.00026549118387909324	IL5,NRAS,IL2RA,IL2RG
528	Cowden syndrome 1	C0018553	2	59	2.2729043709e-05	0.00026599496221662466	STAT5A,STAT5B
529	Hepatitis	C0019159	4	377	2.27530878784e-05	0.0002664987405541562	IL5,IL2,IL2RA,SOS1
544	IgA nephropathy, susceptibility to, 3	C0017661	5	650	2.38333617887e-05	0.0002740554156171285	IL5,IL2,NRAS,IL5RA,JAK3
545	Adverse drug events and drug allergies	C0041755	2	60	2.39106269345e-05	0.00027455919395465996	CSF2,IL3
546	Sarcoidosis, Pulmonary	C0036205	2	60	2.39106269345e-05	0.00027506297229219144	IL2,CSF2
547	Abnormality of bone marrow cell morphology	C4021634	3	183	2.39967317565e-05	0.0002755667506297229	NRAS,IL2RA,IL2RG
548	Cyst	C0010709	3	184	2.45147028509e-05	0.00027607052896725444	CA9,CSF2,SOS1
549	Memory Loss	C0002622	2	61	2.51319236143e-05	0.00027657430730478586	IL2,CSF2
550	Bronchiolitis Obliterans	C0006272	2	61	2.51319236143e-05	0.0002770780856423174	IL2,CSF2
551	Hypersensitivity	C0020517	3	186	2.55750993148e-05	0.00027758186397984887	IL2RB,IL2,IL5RA
552	Squamous cell carcinoma	C0007137	8	1855	2.59464332244e-05	0.00027808564231738035	STAT5A,IL5,IL2,NRAS,CA9,CSF2,IL2RA,SOS1
553	Childhood Leukemia	C1332977	2	62	2.63935755819e-05	0.0002785894206549118	NRAS,CSF2
554	Lymphoma, Follicular	C0024301	4	389	2.64360657963e-05	0.00027909319899244335	STAT5A,IL5,STAT5B,IL2RA
555	Misalignment of teeth	C1852504	3	188	2.66687804454e-05	0.0002795969773299748	IL2RB,IL2RA,SOS1
556	Malignant tumor of prostate	C0376358	10	2940	2.68068027582e-05	0.0002801007556675063	STAT5A,STAT5B,IL2,NRAS,CA9,SHC1,CSF2,JAK1,IL2RA,SOS1
557	Helminthiasis	C0018889	2	63	2.76961755137e-05	0.0002806045340050378	IL5,IL2
558	secondary acute myeloid leukemia	C0280449	2	63	2.76961755137e-05	0.0002811083123425693	INPP5D,IL3
559	Webbed neck	C0221217	2	63	2.76961755137e-05	0.00028161209068010073	NRAS,SOS1
560	Diamond-Blackfan anemia	C1260899	2	63	2.76961755137e-05	0.00028211586901763226	CSF2,IL3
561	Juvenile rheumatoid arthritis	C3714757	3	190	2.77965432763e-05	0.00028261964735516374	IL2RB,IL2,IL2RA
562	Alopecia	C0002170	3	191	2.83733619473e-05	0.0002831234256926952	NRAS,IL2RA,IL2RG
563	Abnormal hair quantity	C4023397	4	395	2.84435334011e-05	0.0002836272040302267	NRAS,IL2RA,SOS1,IL2RG
564	Low posterior hairline	C1855728	2	64	2.90403971929e-05	0.0002841309823677582	NRAS,SOS1
565	Abnormality of the posterior hairline	C4022607	2	64	2.90403971929e-05	0.00028463476070528964	NRAS,SOS1
566	gliosarcoma	C0206726	2	64	2.90403971929e-05	0.00028513853904282117	IL2,SOS1
567	Trachoma	C0040592	2	64	2.90403971929e-05	0.00028564231738035264	IL5RA,CSF2
580	Proportionate short stature	C0205351	2	65	3.04268817244e-05	0.00029219143576826194	INPPL1,STAT5B
581	Progressive supranuclear ophthalmoplegia	C0038868	2	65	3.04268817244e-05	0.00029269521410579347	IL2,CSF2
582	Lipoma	C0023798	2	65	3.04268817244e-05	0.00029319899244332494	STAT5A,STAT5B
583	Colitis, Ulcerative	C0009319	5	679	3.0454726899e-05	0.0002937027707808564	STAT5B,IL2,JAK3,CSF2,IL2RA
584	Malignant neoplasm of kidney	C0740457	4	401	3.05677344988e-05	0.0002942065491183879	IL2,CA9,CSF2,IL2RA
585	Arthritis, Rheumatoid	C0003864	6	1030	3.16880878491e-05	0.0002947103274559194	IL2RB,IL2,NRAS,CSF2,IL3,IL2RA
586	Noonan syndrome 1	C0028326	2	66	3.18561641638e-05	0.00029521410579345085	NRAS,SOS1
587	Chronic hepatitis	C0019189	3	197	3.2020757572e-05	0.0002957178841309824	IL5,IL2,SHC1
588	Abnormal leukocyte count	C0152009	4	406	3.2430614287e-05	0.00029622166246851385	NRAS,JAK3,IL2RA,IL2RG
589	Abnormality of cellular immune system	C4023612	4	406	3.2430614287e-05	0.0002967254408060454	NRAS,JAK3,IL2RA,IL2RG
590	Carcinoma of cervix	C0302592	6	1045	3.47609356455e-05	0.0002972292191435768	STAT5A,STAT5B,IL2,JAK3,CA9,SOS1
591	Pulmonic stenosis	C0034089	2	68	3.48457318503e-05	0.00029773299748110833	NRAS,SOS1
592	Primary immune deficiency disorder	C0398686	2	68	3.48457318503e-05	0.0002982367758186398	JAK3,IL2RG
593	Wide intermamillary distance	C1827524	2	69	3.64072023916e-05	0.0002987405541561713	NRAS,SOS1
594	Abnormality of cells of the lymphoid lineage	C4023027	2	69	3.64072023916e-05	0.00029924433249370276	IL2RA,IL2RG
595	Abnormal intermamillary distance	C4022412	2	69	3.64072023916e-05	0.0002997481108312343	NRAS,SOS1
618	Arteriosclerosis	C0003850	6	1059	3.78474662543e-05	0.00031133501259445845	IL5,IL2,INPP5D,CSF2,IL2RA,SOS1
619	Skin lesion	C0037284	2	70	3.8014050403e-05	0.0003118387909319899	IL2,NRAS
620	Bronchitis	C0006277	2	70	3.8014050403e-05	0.0003123425692695214	CSF2,IL2RG
621	Intraocular melanoma	C0220633	3	206	3.81217711232e-05	0.0003128463476070529	IL2,NRAS,CSF2
622	Retroviridae Infections	C0035369	2	71	3.96667130017e-05	0.0003133501259445844	CSF2,IL2RA
623	 {HIV-1 viremia, susceptibility to}, 609423 (3)	C0042749	2	71	3.96667130017e-05	0.00031385390428211583	IL2,JAK1
624	Myasthenia Gravis	C0026896	3	209	4.03327701388e-05	0.00031435768261964736	IL2RB,IL2,IL2RA
625	Abnormality of joint mobility	C4023216	5	715	4.06625252538e-05	0.00031486146095717883	INPPL1,IL2RB,NRAS,IL2RA,SOS1
626	Abnormality of the pulmonary artery	C0009681	2	72	4.13659327423e-05	0.00031536523929471036	NRAS,SOS1
627	Cancer of Head and Neck	C0278996	4	430	4.26361737801e-05	0.0003158690176322418	STAT5A,STAT5B,IL2,CSF2
628	Endometriosis	C0014175	5	727	4.46196376978e-05	0.0003163727959697733	IL2RB,SHC1,CSF2,JAK1,SOS1
629	Abnormality of the liver	C4021780	5	727	4.46196376978e-05	0.0003168765743073048	INPPL1,NRAS,IL2RA,SOS1,IL2RG
630	Breast Cancer Model	C1511291	2	74	4.49062268831e-05	0.00031738035264483627	IL2,GRB2
631	Pathologic Neovascularization	C0027686	2	74	4.49062268831e-05	0.0003178841309823678	JAK3,CSF2
648	Eating disorder	C0013473	2	75	4.6748588903e-05	0.000326448362720403	IL2RB,CSF2
649	Pleural Effusion, Malignant	C0080032	2	75	4.6748588903e-05	0.0003269521410579345	IL2,IL2RA
650	Abnormal shape of the occiput	C4023459	2	76	4.86397675021e-05	0.000327455919395466	INPPL1,NRAS
651	Blast Phase	C0005699	3	221	5.01260591953e-05	0.00032795969773299747	IL2,NRAS,CSF2
652	Triangular face	C1835884	2	77	5.05806147584e-05	0.00032846347607052895	NRAS,SOS1
653	FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)	C3469521	3	223	5.19131161805e-05	0.0003289672544080605	CSF2,IL3,JAK1
654	pediatric acute myeloblastic leukemia	C0220621	2	78	5.25714733713e-05	0.0003294710327455919	NRAS,IL2RG
655	Alopecia Areata	C0002171	2	79	5.46130430379e-05	0.00032997481108312343	IL2,IL2RA
656	Leukemia, Myeloid, Chronic-Phase	C0023474	2	79	5.46130430379e-05	0.0003304785894206549	NRAS,IL3
657	Other disorders of the nervous system	C0027765	4	454	5.51774868297e-05	0.00033098236775818644	IL2RB,IL2,CSF2,IL2RA
673	Primary pulmonary hypertension	C0152171	3	227	5.56264517076e-05	0.00033904282115869016	STAT5A,STAT5B,CA9
674	Duodenal Ulcer	C0013295	2	80	5.67059481161e-05	0.0003395465994962217	IL2,IL2RA
675	Abnormality of digestive system physiology	C4293692	6	1132	5.78510116787e-05	0.00034005037783375316	INPPL1,NRAS,JAK3,IL2RA,SOS1,IL2RG
676	Multiple Endocrine Neoplasia Type 1	C0025267	2	81	5.88506956594e-05	0.00034055415617128464	NRAS,CSF2
677	Hormone refractory prostate cancer	C1328504	2	81	5.88506956594e-05	0.0003410579345088161	IL2,CSF2
678	Multiple Sclerosis	C0026769	6	1140	6.04921887187e-05	0.00034156171284634764	IL2RB,IL2,IL5RA,CSF2,JAK1,IL2RA
679	Abnormality of the helix	C1856660	2	82	6.10480112486e-05	0.00034206549118387906	NRAS,SOS1
680	Stromal Neoplasm	C0879615	2	82	6.10480112486e-05	0.0003425692695214106	SOS1,IL2RG
681	Tetanus	C0039614	2	82	6.10480112486e-05	0.00034307304785894207	IL5,IL2
682	Virus Diseases	C0042769	5	772	6.23132360682e-05	0.00034357682619647355	IL5,IL2,INPP5D,CSF2,IL2RA
683	Delayed skeletal maturation	C0541764	3	234	6.25871755577e-05	0.000344080604534005	INPPL1,NRAS,SOS1
684	Lichen Planus, Oral	C0206139	2	83	6.32984026695e-05	0.00034458438287153655	IL5,IL2
702	Abnormality of the rib cage	C4025763	3	237	6.57569957146e-05	0.0003536523929471033	INPPL1,NRAS,SOS1
703	Mitral stenosis	C0026269	3	238	6.68392116004e-05	0.0003541561712846348	IL2,CSF2,IL2RA
704	Vitiligo	C0042900	3	241	7.01638300989e-05	0.00035465994962216623	IL2,CSF2,IL2RA
705	Abnormality of metabolism/homeostasis	C4021768	7	1607	7.022759862e-05	0.00035516372795969776	INPPL1,IL2RB,NRAS,JAK3,IL2RA,SOS1,IL2RG
706	Anemia due to reduced life span of red cells	C4021112	2	86	7.03738185496e-05	0.00035566750629722923	NRAS,IL2RA
707	Pectus carinatum	C0158731	2	86	7.03738185496e-05	0.0003561712846347607	NRAS,SOS1
708	Stomach cancer	C0699791	8	2109	7.15996191293e-05	0.0003566750629722922	IL2RB,IL2,NRAS,JAK3,GRB2,CA9,JAK1,SOS1
709	Herpes NOS	C0019340	2	87	7.28423630059e-05	0.0003571788413098237	CSF2,IL2RA
710	Limitation of joint mobility	C1857108	3	244	7.3607639261e-05	0.00035768261964735514	INPPL1,IL2RB,IL2RA
711	Dermatosis NOS	C0037274	4	483	7.39518359471e-05	0.00035818639798488667	IL5,IL2RB,IL2,IL2RA
712	Recurrent upper respiratory tract infections	C0581381	2	88	7.53669188215e-05	0.00035869017632241814	JAK3,IL2RG
730	Plasmacytoma	C0032131	2	89	7.79480053167e-05	0.0003677581863979849	IL2,IL3
731	Major depressive disorder	C1269683	4	489	7.83871281796e-05	0.0003682619647355164	IL2RB,IL2,CSF2RB,IL2RA
732	Fanconi anemia	C0015625	3	249	7.96192115916e-05	0.0003687657430730479	CSF2,IL3,JAK1
733	Abnormality of the sternum	C1860493	3	249	7.96192115916e-05	0.00036926952141057935	INPPL1,NRAS,SOS1
734	Thick lower lip vermilion	C1839739	2	90	8.05863391791e-05	0.0003697732997481109	NRAS,SOS1
735	Thyroid associated opthalmopathies	C0339143	2	90	8.05863391791e-05	0.0003702770780856423	IL5,IL2
736	Latent autoimmune diabetes mellitus in adult	C0205734	2	90	8.05863391791e-05	0.00037078085642317383	IL2,IL2RA
737	Brachydactyly, type a1, d	C0221357	3	250	8.08631661851e-05	0.0003712846347607053	INPPL1,NRAS,SOS1
738	Influenza	C0021400	4	497	8.46175956081e-05	0.0003717884130982368	IL5,IL2,NRAS,IL3
739	Bipolar affective disorder	C0005586	5	817	8.52505522794e-05	0.00037229219143576826	IL2RB,NRAS,CSF2RB,IL2RA,SOS1
749	Follicular adenoma	C0205647	2	94	9.17226422673e-05	0.0003773299748110831	NRAS,SOS1
750	airway disease	C0699949	2	94	9.17226422673e-05	0.0003778337531486146	IL5,IL2RB
751	Prolactinoma, familial	C0033375	2	95	9.46554375156e-05	0.0003783375314861461	STAT5A,STAT5B
752	Abnormality of the pulmonary valve	C3164374	2	95	9.46554375156e-05	0.0003788413098236776	NRAS,SOS1
753	Ulcerative colitis	C0009324	5	837	9.74051511441e-05	0.000379345088161209	STAT5A,IL5,IL2,IL3,IL2RA
754	Increased head circumference	C4083076	3	263	9.83554741375e-05	0.00037984886649874056	INPPL1,NRAS,SOS1
755	Pancreatic Carcinoma	C0235974	7	1690	0.000100201565712	0.00038035264483627203	STAT5B,IL2,CA9,CSF2,JAK1,IL2RA,SOS1
763	Abnormality of the abdominal organs	C4021764	5	842	0.000100650514811	0.00038438287153652395	INPPL1,NRAS,IL2RA,SOS1,IL2RG
764	Abnormal urinary electrolyte concentration	C4022833	2	97	0.00010070329555	0.0003848866498740554	INPPL1,NRAS
765	Neuropathy ataxia retinitis pigmentosa syndrome	C0442874	3	265	0.000101272377562	0.00038539042821158695	IL2,CSF2,IL3
766	Synostosis involving bones of the feet	C0039093	2	98	0.000103819506161	0.0003858942065491184	NRAS,SOS1
767	Alzheimer Disease	C0002395	7	1699	0.000104013339695	0.0003863979848866499	IL2RB,IL2,INPP5D,GRB2,CA9,CSF2,IL3
768	Glomerulonephritis, Membranous	C0017658	3	267	0.000104251627242	0.0003869017632241814	IL2,IL2RA,SOS1
769	Abnormality of skeletal maturation	C4025818	3	268	0.000105764967087	0.00038740554156171286	INPPL1,NRAS,SOS1
770	Advanced cancer	C0877373	2	100	0.000110239485711	0.00038790931989924433	IL2,CSF2
771	Lung cancer	C0684249	8	2234	0.000112152591638	0.00038841309823677586	STAT5B,IL2,NRAS,SHC1,CSF2,JAK1,IL2RA,SOS1
782	Primary adrenal insufficiency	C0001403	2	102	0.000116913200308	0.00039395465994962215	IL2,IL2RA
783	Abnormality of the nasopharynx	C4025750	2	102	0.000116913200308	0.0003944584382871537	JAK3,IL2RG
784	Melanoma, B16	C0004565	2	102	0.000116913200308	0.0003949622166246851	IL2,CSF2
785	Autism 15	C0004352	5	868	0.000118950257191	0.00039546599496221663	IL5,IL2,NRAS,CSF2,SOS1
786	Atherosclerosis	C0004153	6	1271	0.000119988276067	0.0003959697732997481	IL5,IL2,INPP5D,CSF2,IL2RA,SOS1
787	Neoplasm Recurrence, Local	C0027643	3	277	0.00012011374222	0.0003964735516372796	IL2,NRAS,CA9
788	Congenital chromosomal disease	C0008626	4	537	0.000121723400252	0.0003969773299748111	IL2,NRAS,CSF2,IL3
789	Inflammatory disorder	C1290884	3	279	0.000123485141559	0.0003974811083123426	IL5,IL2,CSF2
790	Adult Acute Lymphocytic Leukemia	C0751606	2	104	0.000123845024339	0.0003979848866498741	JAK1,IL2RA
791	Epithelioma	C0553707	3	280	0.000125196353589	0.00039848866498740554	IL2,CA9,SOS1
792	Abnormality of the endocrine system	C4025823	5	878	0.000126658323468	0.00039899244332493707	STAT5B,NRAS,IL2RA,SOS1,IL2RG
793	Psoriasis	C0033860	5	878	0.000126658323468	0.00039949622166246854	IL2,CSF2,IL3,JAK1,IL2RA
794	Macrocephaly, dysmorphic facies, and psychomotor retardation	C0221355	3	281	0.000126924668588	0.0004	INPPL1,NRAS,SOS1
795	Neoplasm of the rectum	C0034885	2	105	0.000127409189127	0.0004005037783375315	NRAS,CA9
796	Hereditary factor VIII deficiency disease	C0019069	2	105	0.000127409189127	0.000401007556675063	IL2,IL2RA
808	Medulloblastoma	C0025149	4	543	0.000128223137659	0.00040705289672544084	IL2RB,GRB2,CSF2,SOS1
809	Posttraumatic stress disorder	C0038436	2	106	0.000131039524134	0.00040755667506297226	STAT5B,IL2
810	polyps	C0032584	3	284	0.000132213899646	0.0004080604534005038	IL5,NRAS,CSF2
811	Abnormality of thyroid morphology	C4023195	2	107	0.00013473671601	0.00040856423173803527	NRAS,IL2RG
812	Malignant tumor of cervix	C0007847	5	889	0.000135592678089	0.00040906801007556674	STAT5A,STAT5B,IL2,JAK3,SOS1
813	Abnormality of skin physiology	C4023527	3	286	0.000135827769009	0.0004095717884130982	NRAS,IL2RA,IL2RG
814	Xenograft Model	C1520166	4	551	0.00013730143992	0.00041007556675062975	IL3RA,IL2,JAK1,IL2RA
815	Teratoma	C0039538	2	108	0.000138501160341	0.00041057934508816117	CSF2,IL3
816	Apraxia	C0003635	2	108	0.000138501160341	0.0004110831234256927	IL2RB,IL2RA
817	Primary sclerosing cholangitis	C0566602	2	109	0.000142333467199	0.0004115869017632242	IL2,IL2RA
830	Helicobacter Infections	C0079487	2	110	0.00014623417419	0.0004181360201511335	IL5,IL2
831	Abnormality of T cell count	C1704258	5	903	0.000147683574393	0.000418639798488665	INPPL1,NRAS,CSF2,SOS1,IL2RG
832	Myocarditis	C0027059	2	112	0.000154243088181	0.0004191435768261965	IL2RA,SOS1
833	Aplasia/Hypoplasia of the eyebrow	C4021956	2	112	0.000154243088181	0.000419647355163728	SOS1,IL2RG
834	Abnormality of coagulation	C1846821	2	113	0.000158352360128	0.00042015113350125943	NRAS,SOS1
835	CNS disorder	C0007682	2	113	0.000158352360128	0.00042065491183879096	CSF2,IL3
845	Abnormal joint morphology	C0240083	5	915	0.000158717777347	0.0004256926952141058	INPPL1,IL2RB,NRAS,IL2RA,SOS1
846	Multicystic renal dysplasia, bilateral	C1840451	2	114	0.000162532158813	0.00042619647355163724	IL3RA,IL3
847	Autoimmune thyroid disease 3	C0178468	2	114	0.000162532158813	0.0004267002518891688	IL5,IL2RA
848	Abnormality of the face	C4025871	7	1817	0.000166318927011	0.00042720403022670025	INPPL1,IL2RB,NRAS,JAK3,IL2RA,SOS1,IL2RG
849	Abnormality of the hairline	C4024297	2	115	0.000166783138347	0.0004277078085642317	NRAS,SOS1
850	Gastric ulcer	C0038358	2	116	0.000171105776889	0.0004282115869017632	IL2,SOS1
851	Meningitis	C0497299	2	116	0.000171105776889	0.00042871536523929473	JAK3,CSF2
852	Abnormality of dental morphology	C0040427	4	578	0.000171636942525	0.0004292191435768262	IL2RB,NRAS,IL2RA,SOS1
853	Abnormality of upper limb bone	C4022454	3	305	0.000173831458076	0.0004297229219143577	INPPL1,NRAS,SOS1
854	Reperfusion Injury	C0035126	3	305	0.000173831458076	0.0004302267002518892	STAT5A,STAT5B,INPP5D
870	Increased inflammatory response	C4022803	4	581	0.000175824016918	0.000438287153652393	IL2RB,JAK3,IL2RA,IL2RG
871	Abnormal inflammatory response	C4022805	4	581	0.000175824016918	0.0004387909319899244	IL2RB,JAK3,IL2RA,IL2RG
872	Abnormality of the intestine	C0021831	4	584	0.000180089030252	0.00043929471032745594	IL5,NRAS,JAK3,IL2RA
873	Abnormality of the ulna	C4025662	2	119	0.000184509159288	0.0004397984886649874	NRAS,SOS1
874	Abnormality of skin adnexa morphology	C4023518	5	942	0.000185953032793	0.0004403022670025189	INPPL1,NRAS,IL2RA,SOS1,IL2RG
880	High forehead	C0239676	2	121	0.000193813008654	0.0004433249370277078	NRAS,SOS1
881	Pulmonary arterial hypertension	C3203102	3	314	0.000194288222148	0.0004438287153652393	STAT5A,STAT5B,CA9
882	Thick vermilion border	C1836543	2	122	0.000198576936301	0.0004443324937027708	NRAS,SOS1
883	Peripheral T-Cell Lymphoma	C0079774	2	122	0.000198576936301	0.0004448362720403023	IL2RB,CSF2
884	Leiomyoma	C0023267	3	316	0.000199060500546	0.00044534005037783376	IL2,GRB2,CSF2
885	Abnormality of the midface	C4021811	3	317	0.000201478135029	0.0004458438287153653	INPPL1,NRAS,SOS1
886	Sepsis	C0243026	4	602	0.000207371958714	0.0004463476070528967	IL2,CSF2,IL2RA,IL2RG
887	Pancytopenia	C0030312	2	124	0.000208331550394	0.00044685138539042824	NRAS,CSF2
888	Urticaria	C0042109	2	124	0.000208331550394	0.0004473551637279597	IL2RA,IL2RG
889	Abnormality of hair texture	C4023722	2	124	0.000208331550394	0.0004478589420654912	NRAS,SOS1
890	Abnormal nipple morphology	C3839073	2	124	0.000208331550394	0.00044836272040302266	NRAS,SOS1
891	Acute Coronary Syndrome	C0948089	3	320	0.000208858702078	0.0004488664987405542	STAT5A,STAT5B,IL2RA
913	Diabetic Nephropathies	C0011881	4	616	0.000230696139656	0.0004599496221662469	STAT5A,INPPL1,STAT5B,SOS1
914	Renal cell carcinoma, nonpapillary	C0007134	6	1418	0.000236721321605	0.00046045340050377835	IL2,NRAS,CA9,CSF2,IL2RA,SOS1
915	Uterine leiomyoma	C0042133	3	331	0.000237599211755	0.00046095717884130983	IL2,GRB2,CSF2
916	Periodontitis	C0031099	3	331	0.000237599211755	0.00046146095717884136	IL2,CSF2,IL2RA
917	Abnormality of the pharynx	C4025838	2	130	0.000239447286943	0.0004619647355163728	JAK3,IL2RG
918	Failure to thrive	C0015544	4	622	0.000241284860055	0.0004624685138539043	STAT5B,JAK3,CSF2,IL2RG
919	Pulmonary hypertension, neonatal, susceptibility to	C0020542	3	333	0.000243115957826	0.0004629722921914358	STAT5A,CA9,CSF2
920	Hypoxia	C0003130	3	335	0.000248724644624	0.00046347607052896726	STAT5B,CA9,JAK1
921	Pleural Tuberculosis	C0041326	1	25	0.000249329828961	0.00046397984886649874	IL2RA
922	Latent Tuberculosis	C1609538	1	25	0.000249329828961	0.00046448362720403027	IL2RA
923	Flushing	C0016382	1	25	0.000249329828961	0.0004649874055415617	CSF2
924	Blue irides	C0578626	1	25	0.000249329828961	0.0004654911838790932	SOS1
925	Deep philtrum	C1839797	1	25	0.000249329828961	0.0004659949622166247	NRAS
926	Leg Ulcer	C0023223	1	25	0.000249329828961	0.0004664987405541562	SOS1
927	Post-transplant lymphoproliferative disorder	C0432487	1	25	0.000249329828961	0.00046700251889168765	NRAS
928	Rheumatoid Nodule	C0035450	1	25	0.000249329828961	0.0004675062972292192	IL2
929	Chronic berylliosis	C0221052	1	25	0.000249329828961	0.00046801007556675065	IL2
930	Intraepithelial Neoplasia	C0878500	2	132	0.000250450279794	0.00046851385390428213	STAT5A,STAT5B
931	Gingival Diseases	C0017563	2	132	0.000250450279794	0.0004690176322418136	IL2,IL2RA
932	Pain	C0030193	4	628	0.000252241380405	0.00046952141057934513	IL2RB,IL2,CSF2,IL2RA
933	Abnormality of the pulmonary vasculature	C4025271	2	133	0.000256072473485	0.00047002518891687655	NRAS,SOS1
934	Metastatic malignant neoplasm to brain	C0220650	2	133	0.000256072473485	0.0004705289672544081	NRAS,CSF2
935	 {Aerodigestive tract cancer, squamous cell, alcohol-related, protection against} (3)	C0751688	2	134	0.000261775800374	0.00047103274559193956	IL2,CSF2
936	Thyroiditis	C0040147	2	134	0.000261775800374	0.00047153652392947104	IL2RA,IL2RG
937	Congenital abnormal hair pattern	C4023398	2	134	0.000261775800374	0.0004720403022670025	NRAS,SOS1
938	Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis	C1853242	2	134	0.000261775800374	0.00047254408060453404	NRAS,SOS1
939	Anaplastic Oligodendroglioma	C0334590	2	135	0.000267560746004	0.00047304785894206546	IL2RB,IL2
940	Non-medullary thyroid carcinoma	C3501843	1	26	0.000269952720331	0.000473551637279597	NRAS
941	Narcolepsy-Cataplexy Syndrome	C0751362	1	26	0.000269952720331	0.00047405541561712847	CSF2
942	Sarcoma, Epithelioid	C0205944	1	26	0.000269952720331	0.00047455919395465994	IL2
943	Hypoplasia of the thymus	C0685891	1	26	0.000269952720331	0.0004750629722921914	IL2RG
944	Peritoneal Mesothelioma	C0346109	1	26	0.000269952720331	0.00047556675062972295	JAK3
945	Acute-Phase Reaction	C0001349	1	26	0.000269952720331	0.00047607052896725437	STAT5B
946	Hemorrhagic Fever with Renal Syndrome	C0019101	1	26	0.000269952720331	0.0004765743073047859	IL2RA
947	Acute hepatitis	C0267797	1	26	0.000269952720331	0.00047707808564231743	SOS1
948	Papillary adenocarcinoma	C0001420	1	26	0.000269952720331	0.00047758186397984885	NRAS
949	Granulocytic Sarcoma	C0152276	1	26	0.000269952720331	0.0004780856423173804	IL2RA
950	Congenital short bowel syndrome	C0021847	1	26	0.000269952720331	0.00047858942065491186	SOS1
951	Small cell lung cancer	C0149925	4	638	0.000271342880583	0.00047909319899244333	IL2,CSF2,IL2RA,SOS1
952	Myositis	C0027121	2	136	0.00027342787754	0.0004795969773299748	IL5,CSF2
953	Motor Neuron Disease	C0085084	2	136	0.00027342787754	0.00048010075566750634	CSF2,SOS1
954	Sjogren's Syndrome	C1527336	2	137	0.000279377660013	0.00048060453400503776	IL2,IL2RA
955	Lung Diseases, Interstitial	C0206062	2	138	0.000285410588244	0.0004811083123425693	IL2,CSF2RA
956	Pruritus	C0033774	2	138	0.000285410588244	0.00048161209068010077	NRAS,IL2RG
957	Synostosis of joints	C4022183	2	138	0.000285410588244	0.00048211586901763224	NRAS,SOS1
958	Cervical dysplasia	C0007868	1	27	0.000291382030219	0.0004826196473551637	CA9
959	Steroid-sensitive nephrotic syndrome	C0403396	1	27	0.000291382030219	0.00048312342569269525	IL2
960	Tuberculosis, Meningeal	C0041318	1	27	0.000291382030219	0.0004836272040302267	CSF2
961	Invasive Skin Melanoma	C1708565	1	27	0.000291382030219	0.0004841309823677582	NRAS
962	Seborrheic keratosis	C0022603	1	27	0.000291382030219	0.0004846347607052897	NRAS
963	Syphilis	C0039128	1	27	0.000291382030219	0.0004851385390428212	CSF2
964	Aplasia/Hypoplasia of the thymus	C4023796	1	27	0.000291382030219	0.0004856423173803526	IL2RG
965	Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads	C0237849	1	27	0.000291382030219	0.00048614609571788416	IL2RG
966	Lyme Disease	C0024198	2	140	0.000297728020717	0.00048664987405541563	SHC1,CSF2
967	Abnormality of the nose	C0265736	5	1028	0.000298303841258	0.0004871536523929471	INPPL1,NRAS,JAK3,SOS1,IL2RG
968	Acquired CJD	C2931859	1	28	0.000313616495676	0.0004876574307304786	CSF2
969	Bovine Anaplasmosis	C0002797	1	28	0.000313616495676	0.0004881612090680101	IL2
970	Periodontal Attachment Loss	C0206114	1	28	0.000313616495676	0.0004886649874055415	IL2
971	Epidermolysis bullosa simplex, Cockayne-Touraine type	C0079298	1	28	0.000313616495676	0.000489168765743073	IL2
972	Papillon-Lefevre Disease	C0030360	1	28	0.000313616495676	0.0004896725440806045	IL2
973	Tick-Borne Encephalitis	C0014061	1	28	0.000313616495676	0.0004901763224181361	IL2
974	Otitis Media with Effusion	C0029883	1	28	0.000313616495676	0.0004906801007556674	IL5
975	Chronic mucocutaneous candidiasis	C0006845	1	28	0.000313616495676	0.000491183879093199	IL2RG
976	Astrocytoma, low grade	C1314694	1	28	0.000313616495676	0.0004916876574307305	CA9
977	Mycosis Fungoides	C0026948	2	143	0.000316840417788	0.000492191435768262	IL5,IL2
978	Abnormality of the head	C4021812	7	1995	0.000316919983342	0.0004926952141057934	INPPL1,IL2RB,NRAS,JAK3,IL2RA,SOS1,IL2RG
979	Monoclonal Gammopathy of Undetermined Significance	C0026470	2	144	0.00032338290203	0.0004931989924433249	NRAS,IL2RA
980	Chronic liver disease	C0341439	2	144	0.00032338290203	0.0004937027707808565	IL2,SOS1
981	Neoplasm of the central nervous system	C0085136	2	145	0.000330012061598	0.0004942065491183879	NRAS,SOS1
982	Recurrent viral infections	C1837066	1	29	0.000336654542074	0.0004947103274559195	IL2RA
983	Autoimmune thrombocytopenia	C0242584	1	29	0.000336654542074	0.0004952141057934509	NRAS
984	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	C1292772	1	29	0.000336654542074	0.0004957178841309824	CSF2
985	Abnormality of the pubic bone	C4021738	1	29	0.000336654542074	0.0004962216624685139	INPPL1
986	Hypogammaglobulinemia	C0086438	1	29	0.000336654542074	0.0004967254408060454	CSF2
987	Pyruvate carboxylase deficiency	C0034341	1	29	0.000336654542074	0.0004972292191435768	NRAS
988	Abnormality of head or neck	C0854297	7	2021	0.000346243167422	0.0004977329974811083	INPPL1,IL2RB,NRAS,JAK3,IL2RA,SOS1,IL2RG
989	Astrocytoma	C0004114	4	674	0.000349392355348	0.0004982367758186398	STAT5A,STAT5B,CA9,CSF2
990	Joint hyperflexibility	C3553764	2	148	0.000350424614711	0.0004987405541561713	NRAS,SOS1
991	Abnormal hair pattern	C4023721	2	148	0.000350424614711	0.0004992443324937027	NRAS,SOS1
992	Clear cell renal cell carcinoma	C0279702	3	368	0.000355349297334	0.0004997481108312343	IL2,CA9,SOS1
993	Arthralgia	C0003862	2	149	0.000357405410795	0.0005002518891687657	IL2RB,IL2RA
994	Recurrent bronchitis	C0741796	1	30	0.000360494877724	0.0005007556675062972	IL2RG
995	Chromophobe Renal Cell Carcinoma	C1266042	1	30	0.000360494877724	0.0005012594458438288	CA9
996	Cubitus valgus	C0158465	1	30	0.000360494877724	0.0005017632241813602	SOS1
997	Familial cold-induced inflammatory syndrome 1, 120100 (3)	C0009443	1	30	0.000360494877724	0.0005022670025188917	IL2
998	Oral aphthae	C0038363	1	30	0.000360494877724	0.0005027707808564232	IL2
999	pricking of skin	C0476227	1	30	0.000360494877724	0.0005032745591939547	IL2RA
1000	Isolated somatotropin deficiency	C3714796	1	30	0.000360494877724	0.0005037783375314861	STAT5B
1001	Disorder of amino acid metabolism	C0002514	1	30	0.000360494877724	0.0005042821158690176	CSF2
1002	Abnormality of the radius	C4025675	2	151	0.000371634928856	0.0005047858942065491	NRAS,SOS1
1003	Abnormality of erythrocytes	C0391870	3	374	0.000377774417831	0.0005052896725440807	NRAS,IL2RA,IL2RG
1004	Distal myopathy Markesbery-Griggs type	C1838244	1	31	0.0003851360489	0.0005057934508816121	JAK3
1005	Creutzfeldt-Jakob Disease, Sporadic	C1852467	1	31	0.0003851360489	0.0005062972292191435	CSF2
1006	HYPER-IgM IMMUNODEFICIENCY, X-LINKED, WITH ECTODERMAL DYSPLASIA, HYPOHIDROTIC	C0398689	1	31	0.0003851360489	0.000506801007556675	IL2RA
1007	Abnormality of eosinophils	C4025738	1	31	0.0003851360489	0.0005073047858942066	IL2RG
1008	Hypersomnia	C0917799	1	31	0.0003851360489	0.000507808564231738	CSF2
1009	Monocytosis	C0085702	1	31	0.0003851360489	0.0005083123425692695	NRAS
1010	Myasthenic syndrome, congenital, 8	C0022972	1	31	0.0003851360489	0.0005088161209068011	IL2RA
1011	Malignant melanoma of eye	C0558356	1	31	0.0003851360489	0.0005093198992443326	NRAS
1012	Herpes simplex encephalitis, susceptibility to, 7	C0276226	1	31	0.0003851360489	0.000509823677581864	CSF2
1013	Hypophosphatemic rickets	C3536983	1	31	0.0003851360489	0.0005103274559193954	NRAS
1014	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	C0002878	2	153	0.00038622493563	0.000510831234256927	NRAS,IL2RA
1015	Hereditary pancreatitis	C0238339	3	377	0.000389359761399	0.0005113350125944585	IL2RB,IL2RA,SOS1
1016	Secondary malignant neoplasm of pancreas	C3266877	6	1540	0.000392391418743	0.00051183879093199	INPPL1,IL2,NRAS,CA9,CSF2,SOS1
1017	Invasive Carcinoma	C1334274	2	154	0.00039365637991	0.0005123425692695214	IL5,CA9
1018	Thalassemia	C0039730	2	154	0.00039365637991	0.0005128463476070529	IL3,IL2RA
1019	Diarrhea 8, secretory sodium, congenital	C0011991	3	379	0.000397223633732	0.0005133501259445844	JAK3,IL2RA,IL2RG
1020	Inflammatory abnormality of the eye	C4020969	2	155	0.000401179298181	0.0005138539042821159	IL2RB,IL2RA
1021	3 beta-Hydroxysteroid dehydrogenase deficiency	C1291311	1	32	0.000410576794396	0.0005143576826196473	CSF2
1022	Familial Alzheimer Disease (FAD)	C0276496	1	32	0.000410576794396	0.0005148614609571789	CSF2
1023	TNF receptor-associated periodic fever syndrome (TRAPS)	C3889979	1	32	0.000410576794396	0.0005153652392947104	IL2RB
1024	Respiratory Hypersensitivity	C0035228	1	32	0.000410576794396	0.0005158690176322418	IL2
1025	Pleomorphic adenoma of salivary gland	C1519176	1	32	0.000410576794396	0.0005163727959697732	IL2RA
1026	Interstitial lung and liver disease	C0206061	1	32	0.000410576794396	0.0005168765743073048	IL2RA
1027	Niemann-Pick disease, type C	C0220756	1	32	0.000410576794396	0.0005173803526448363	CSF2
1028	Insulinoma	C0021670	2	157	0.000416501815845	0.0005178841309823678	STAT5A,STAT5B
1029	Abnormal dermatoglyphics	C0432333	2	157	0.000416501815845	0.0005183879093198993	NRAS,SOS1
1030	Malignant neoplasm of brain and nervous system	C0153633	2	157	0.000416501815845	0.0005188916876574307	IL2,CA9
1031	Abnormality of the neck	C0266623	3	384	0.000417381136469	0.0005193954659949622	INPPL1,NRAS,SOS1
1032	Abnormal QRS complex	C0205161	5	1098	0.000424607765959	0.0005198992443324937	INPPL1,NRAS,IL2RA,SOS1,IL2RG
1033	Follicular neoplasm	C0474808	1	33	0.000436815493978	0.0005204030226700252	NRAS
1034	Asymptomatic Infections	C0275522	1	33	0.000436815493978	0.0005209068010075567	CSF2
1035	Periodontal Pocket	C0031094	1	33	0.000436815493978	0.0005214105793450882	IL2
1036	Normal pressure hydrocephalus	C0020258	1	33	0.000436815493978	0.0005219143576826196	CSF2
1037	Prostate Cancer, Hereditary, 7	C1853195	1	33	0.000436815493978	0.0005224181360201511	SOS1
1038	Porencephaly	C0151860	1	33	0.000436815493978	0.0005229219143576826	NRAS
1039	Stage IV Ovarian Carcinoma	C0278688	1	33	0.000436815493978	0.0005234256926952141	CSF2
1040	Abnormality of cells of the monocyte/macrophage lineage	C4023025	1	33	0.000436815493978	0.0005239294710327456	NRAS
1041	Uterine leiomyosarcoma	C0280631	1	33	0.000436815493978	0.0005244332493702772	NRAS
1042	Oestrogen deficiency	C0853662	1	33	0.000436815493978	0.0005249370277078087	IL2RG
1043	IgG deficiency	C0162539	1	33	0.000436815493978	0.00052544080604534	IL2RG
1044	Flat occiput	C1837402	1	33	0.000436815493978	0.0005259445843828715	INPPL1
1045	VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)	C1847835	2	160	0.00044018439745	0.0005264483627204031	IL2,CSF2
1046	Abnormality of lower lip	C4025883	2	160	0.00044018439745	0.0005269521410579346	NRAS,SOS1
1047	Abnormality of the oral cavity	C4025887	5	1109	0.000447792029077	0.000527455919395466	INPPL1,IL2RB,NRAS,IL2RA,SOS1
1048	Growth abnormality	C0262361	6	1578	0.000454986978968	0.0005279596977329975	INPPL1,STAT5B,NRAS,JAK3,SOS1,IL2RG
1049	{Systemic lupus erythematosus, susceptibility to, 8} (2)	C0409974	3	393	0.000455497104697	0.000528463476070529	IL5,IL2,IL2RA
1050	Irritable bowel syndrome with diarrhea	C0022104	2	162	0.000456444170026	0.0005289672544080605	IL2,IL2RA
1051	Abnormality of facial skeleton	C2315229	4	715	0.000457917031134	0.0005294710327455919	INPPL1,NRAS,SOS1,IL2RG
1052	Meningitis, Pneumococcal	C0025295	1	34	0.000463850972426	0.0005299748110831234	CSF2
1053	Encephalomyelitis	C0014070	1	34	0.000463850972426	0.000530478589420655	CSF2
1054	Systemic aspergillosis	C0004030	1	34	0.000463850972426	0.0005309823677581865	CSF2
1055	Adenoviral infections	C0851887	1	34	0.000463850972426	0.0005314861460957178	CSF2
1056	Erythrocytosis	C1527405	1	34	0.000463850972426	0.0005319899244332493	JAK1
1057	Prostate cancer recurrent	C0278838	1	34	0.000463850972426	0.0005324937027707809	CSF2
1058	Steroid-resistant nephrotic syndrome	C3266102	1	34	0.000463850972426	0.0005329974811083124	IL2
1059	Bisphosphonate-associated osteonecrosis	C2986536	1	34	0.000463850972426	0.0005335012594458439	NRAS
1060	Therapy-related myelodysplastic syndrome	C1292780	1	34	0.000463850972426	0.0005340050377833753	CSF2
1061	Abnormality of forearm bone	C4022452	2	163	0.000464716917457	0.0005345088161209068	NRAS,SOS1
1062	Acquired Immunodeficiency Syndrome	C0001175	2	163	0.000464716917457	0.0005350125944584383	IL5,IL2
1063	Abnormality of thyroid physiology	C0857576	2	164	0.000473085486495	0.0005355163727959698	IL2RA,IL2RG
1064	Abnormality of the forearm	C4025666	2	165	0.000481550350244	0.0005360201511335012	NRAS,SOS1
1065	Antisocial Personality Disorder	C0003431	1	35	0.000491681674392	0.0005365239294710328	CSF2
1066	Asymmetric growth	C4022025	1	35	0.000491681674392	0.0005370277078085643	NRAS
1067	Enterovirus Infections	C0014378	1	35	0.000491681674392	0.0005375314861460957	CSF2
1068	Paranoid Schizophrenia	C0036349	1	35	0.000491681674392	0.0005380352644836271	IL2
1069	Rhinitis, Allergic, Perennial	C0035457	1	35	0.000491681674392	0.0005385390428211587	IL5
1070	Equine Infectious Anemia	C0014661	1	35	0.000491681674392	0.0005390428211586902	IL2
1071	Lupus Erythematosus, Cutaneous	C0024137	1	35	0.000491681674392	0.0005395465994962217	IL2RA
1072	Volvulus	C0042961	1	35	0.000491681674392	0.0005400503778337533	IL5
1073	Enteritis	C0014335	1	35	0.000491681674392	0.0005405541561712846	STAT5B
1074	Unipolar Depression	C0041696	3	406	0.000514867932156	0.0005410579345088161	IL2RB,CSF2RB,IL2RA
1075	Behcet Syndrome	C0004943	3	407	0.000519652557567	0.0005415617128463476	IL2,JAK1,IL2RA
1076	Prolonged bleeding time	C0439590	1	36	0.000520306253865	0.0005420654911838792	SOS1
1077	Chronic schizophrenia	C0221765	1	36	0.000520306253865	0.0005425692695214106	IL2RG
1078	HTLV-I Infections	C0020097	1	36	0.000520306253865	0.0005430730478589421	IL2
1079	Hemangioblastoma	C0206734	1	36	0.000520306253865	0.0005435768261964736	CA9
1080	Horseshoe kidney	C0221353	1	36	0.000520306253865	0.0005440806045340051	NRAS
1081	Metastatic Carcinoma	C1384494	1	36	0.000520306253865	0.0005445843828715365	IL2
1082	Polymyalgia Rheumatica	C0032533	1	36	0.000520306253865	0.000545088161209068	IL2RA
1083	Malignant ascites	C0220656	1	36	0.000520306253865	0.0005455919395465995	IL2
1084	Microscopic Polyarteritis	C2347126	1	36	0.000520306253865	0.0005460957178841311	IL2
1085	Vascular Diseases	C0042373	3	410	0.000534197213874	0.0005465994962216625	STAT5A,STAT5B,IL2
1086	Amyotrophic lateral sclerosis type 1	C1862939	2	171	0.000534388627938	0.0005471032745591939	JAK3,SHC1
1087	Proptosis	C0015300	2	171	0.000534388627938	0.0005476070528967254	NRAS,SOS1
1088	Malignant Glioma	C0555198	3	412	0.000544053816003	0.000548110831234257	CA9,CSF2,SOS1
